[go: up one dir, main page]

Next Issue
Volume 12, October
Previous Issue
Volume 12, August
 
 

Viruses, Volume 12, Issue 9 (September 2020) – 154 articles

Cover Story (view full-size image): The HIV-1 integrase enzyme (IN) plays a critical role in the viral life cycle by integrating the reverse-transcribed viral DNA into the host chromosome. Recent discoveries unveiled that IN has an equally vital, yet understudied, second function in human immunodeficiency virus type 1 (HIV-1) replication. IN binds to the viral RNA genome in virions, and IN-RNA binding is necessary for proper virion maturation and morphogenesis. Inhibition of IN binding to the viral RNA genome results in mislocalization of the viral genome inside the virus particle, and its premature exposure and degradation in target cells. The discovery of this novel function of IN presents an attractive therapeutic target. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
24 pages, 1121 KiB  
Review
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
by Zheng Yao Low, Isra Ahmad Farouk and Sunil Kumar Lal
Viruses 2020, 12(9), 1058; https://doi.org/10.3390/v12091058 - 22 Sep 2020
Cited by 107 | Viewed by 9399
Abstract
Traditionally, drug discovery utilises a de novo design approach, which requires high cost and many years of drug development before it reaches the market. Novel drug development does not always account for orphan diseases, which have low demand and hence low-profit margins for [...] Read more.
Traditionally, drug discovery utilises a de novo design approach, which requires high cost and many years of drug development before it reaches the market. Novel drug development does not always account for orphan diseases, which have low demand and hence low-profit margins for drug developers. Recently, drug repositioning has gained recognition as an alternative approach that explores new avenues for pre-existing commercially approved or rejected drugs to treat diseases aside from the intended ones. Drug repositioning results in lower overall developmental expenses and risk assessments, as the efficacy and safety of the original drug have already been well accessed and approved by regulatory authorities. The greatest advantage of drug repositioning is that it breathes new life into the novel, rare, orphan, and resistant diseases, such as Cushing’s syndrome, HIV infection, and pandemic outbreaks such as COVID-19. Repositioning existing drugs such as Hydroxychloroquine, Remdesivir, Ivermectin and Baricitinib shows good potential for COVID-19 treatment. This can crucially aid in resolving outbreaks in urgent times of need. This review discusses the past success in drug repositioning, the current technological advancement in the field, drug repositioning for personalised medicine and the ongoing research on newly emerging drugs under consideration for the COVID-19 treatment. Full article
(This article belongs to the Special Issue Drug-Repositioning Opportunities for Antiviral Therapy)
Show Figures

Figure 1

Figure 1
<p>A summary of the strategy, significance and limitations of common computational approaches in drug repositioning.</p>
Full article ">Figure 2
<p>(<b>a</b>) Traditional de novo drug discovery takes up to 17 years from drug identification to market. (<b>b</b>) In-vitro and in-vivo screening, validation, lead optimisation, and efficacy studies require significantly lesser time thus resulting in significant time overall time saved and reduced overall cost.</p>
Full article ">
18 pages, 2210 KiB  
Article
An Unconventional Flavivirus and Other RNA Viruses in the Sea Cucumber (Holothuroidea; Echinodermata) Virome
by Ian Hewson, Mitchell R. Johnson and Ian R. Tibbetts
Viruses 2020, 12(9), 1057; https://doi.org/10.3390/v12091057 - 22 Sep 2020
Cited by 14 | Viewed by 5312
Abstract
Sea cucumbers (Holothuroidea; Echinodermata) are ecologically significant constituents of benthic marine habitats. We surveilled RNA viruses inhabiting eight species (representing four families) of holothurian collected from four geographically distinct locations by viral metagenomics, including a single specimen of Apostichopus californicus affected by a [...] Read more.
Sea cucumbers (Holothuroidea; Echinodermata) are ecologically significant constituents of benthic marine habitats. We surveilled RNA viruses inhabiting eight species (representing four families) of holothurian collected from four geographically distinct locations by viral metagenomics, including a single specimen of Apostichopus californicus affected by a hitherto undocumented wasting disease. The RNA virome comprised genome fragments of both single-stranded positive sense and double stranded RNA viruses, including those assigned to the Picornavirales, Ghabrivirales, and Amarillovirales. We discovered an unconventional flavivirus genome fragment which was most similar to a shark virus. Ghabivirales-like genome fragments were most similar to fungal totiviruses in both genome architecture and homology and had likely infected mycobiome constituents. Picornavirales, which are commonly retrieved in host-associated viral metagenomes, were similar to invertebrate transcriptome-derived picorna-like viruses. The greatest number of viral genome fragments was recovered from the wasting A. californicus library compared to the asymptomatic A. californicus library. However, reads from the asymptomatic library recruited to nearly all recovered wasting genome fragments, suggesting that they were present but not well represented in the grossly normal specimen. These results expand the known host range of flaviviruses and suggest that fungi and their viruses may play a role in holothurian ecology. Full article
(This article belongs to the Collection Unconventional Viruses)
Show Figures

Figure 1

Figure 1
<p>Contig map of <span class="html-italic">Apostichopus californicus</span> flavivirus-like contig 91. The open reading frame matched a flavivirus polyprotein by BLASTx [<a href="#B37-viruses-12-01057" class="html-bibr">37</a>]. Methyltransferase, NS5 and helicase domains were identified by comparison against the conserved domain database (CDD) at NCBI [<a href="#B41-viruses-12-01057" class="html-bibr">41</a>]. The location of the envelope region was determined by protein folding comparison in Phyre [<a href="#B39-viruses-12-01057" class="html-bibr">39</a>]. The hairpin like structure preceding the Envelope region was determined by folding all sites between start (AUG) codons by mFold [<a href="#B40-viruses-12-01057" class="html-bibr">40</a>].</p>
Full article ">Figure 2
<p>Phylogenetic representation of <span class="html-italic">Apostichopus californicus</span> flavivirus-like contig 91. The tree was constructed by performing an alignment of overlapping regions with best BLASTx matches at NCBI using the CLC Sequence Viewer 8.0 native alignment algorithm. The tree is based on a ~420 amino acid alignment by neighbor joining and based on Jukes-Cantor distance. Values above nodes indicate bootstrap statistics (&gt;50%) based on 1000 iterations. The green branches indicate the emerging aquatic and invertebrate-associated flavivirus clade [<a href="#B52-viruses-12-01057" class="html-bibr">52</a>]. An additional phylogenetic representation based on maximum likelihood is provided in the <a href="#app1-viruses-12-01057" class="html-app">Supplementary Materials</a>.</p>
Full article ">Figure 3
<p>Contig maps for <span class="html-italic">Picornavirales</span>-like genome fragments recovered from holothurians by viral metagenomics. The expect values of best matches by BLASTx against the non-redundant database at NCBI are indicated to the right of each contig. Solid lines indicate the total contig length, and arrows indicate open reading frames. Colored bars indicate shared homology between contigs based on reciprocal tBLASTx.</p>
Full article ">Figure 4
<p>Phylogenetic representation of holothurian-associated <span class="html-italic">Picornavirales</span>-like genome fragments. The tree was constructed by performing an alignment of an overlapping region (~100 amino acid) of the rhv domain with best BLASTx matches in the non-redundant database at NCBI. The tree was constructed by neighbor joining and based on Jukes-Cantor distance. Values above nodes indicate bootstrap statistics (&gt;50%) based on 1000 iterations. An additional phylogenetic representation based on maximum likelihood is provided in the <a href="#app1-viruses-12-01057" class="html-app">Supplementary Materials</a>.</p>
Full article ">Figure 5
<p>Contig maps for totivirus-like genome fragments recovered from holothurians. The expected values of best matches by BLASTx [<a href="#B37-viruses-12-01057" class="html-bibr">37</a>] to the non-redundant database at NCBI are indicated to the right of the contigs. Solid lines indicate the total contig length, and arrows indicate open reading frames. RdRp = RNA-dependent RNA polymerase, Cp = capsid protein.</p>
Full article ">Figure 6
<p>Phylogenetic representations of holothurian-associated totivirus-like genome fragments. The trees were constructed by performing an alignment of an overlapping region of the RdRp (<b>top</b>) and Cp (<b>bottom</b>) domains with best BLASTx matches at NCBI. The trees are based on ~156 amino acid (for RdRp) and 87 amino acid (for Cp) alignments by neighbor joining and based on Jukes-Cantor distance. Values above nodes indicate bootstrap statistics (&gt;50%) based on 1000 iterations. An additional phylogenetic representation based on maximum likelihood is provided in the <a href="#app1-viruses-12-01057" class="html-app">Supplementary Materials</a>.</p>
Full article ">
23 pages, 7699 KiB  
Article
A Unique Relative of Rotifer Birnavirus Isolated from Australian Mosquitoes
by Caitlin A. O’Brien, Cassandra L. Pegg, Amanda S. Nouwens, Helle Bielefeldt-Ohmann, Bixing Huang, David Warrilow, Jessica J. Harrison, John Haniotis, Benjamin L. Schulz, Devina Paramitha, Agathe M. G. Colmant, Natalee D. Newton, Stephen L. Doggett, Daniel Watterson, Jody Hobson-Peters and Roy A. Hall
Viruses 2020, 12(9), 1056; https://doi.org/10.3390/v12091056 - 22 Sep 2020
Cited by 9 | Viewed by 4234
Abstract
The family Birnaviridae are a group of non-enveloped double-stranded RNA viruses which infect poultry, aquatic animals and insects. This family includes agriculturally important pathogens of poultry and fish. Recently, next-generation sequencing technologies have identified closely related birnaviruses in Culex, Aedes and Anopheles mosquitoes. [...] Read more.
The family Birnaviridae are a group of non-enveloped double-stranded RNA viruses which infect poultry, aquatic animals and insects. This family includes agriculturally important pathogens of poultry and fish. Recently, next-generation sequencing technologies have identified closely related birnaviruses in Culex, Aedes and Anopheles mosquitoes. Using a broad-spectrum system based on detection of long double-stranded RNA, we have discovered and isolated a birnavirus from Aedes notoscriptus mosquitoes collected in northern New South Wales, Australia. Phylogenetic analysis of Aedes birnavirus (ABV) showed that it is related to Rotifer birnavirus, a pathogen of microscopic aquatic animals. In vitro cell infection assays revealed that while ABV can replicate in Aedes-derived cell lines, the virus does not replicate in vertebrate cells and displays only limited replication in Culex- and Anopheles-derived cells. A combination of SDS-PAGE and mass spectrometry analysis suggested that the ABV capsid precursor protein (pVP2) is larger than that of other birnaviruses and is partially resistant to trypsin digestion. Reactivity patterns of ABV-specific polyclonal and monoclonal antibodies indicate that the neutralizing epitopes of ABV are SDS sensitive. Our characterization shows that ABV displays a number of properties making it a unique member of the Birnaviridae and represents the first birnavirus to be isolated from Australian mosquitoes. Full article
Show Figures

Figure 1

Figure 1
<p>Isolation and prevalence of Aedes birnavirus (ABV). (<b>a</b>) Summary of screening for ABV and known insect-specific viruses (ISVs) in MAVRIC-positive mosquito pools collected in NSW between 2013 and 2014. (<b>b</b>) Anti-double-stranded RNA (dsRNA) immunolabeling in C6/36 cells inoculated with mosquito pools 177833 and 178287, or mock infected (media only) in immunofluorescence assay. Images were taken at 63× magnification. Green: dsRNA. Blue: nuclei. (<b>c</b>) C6/36 cells infected with ABV isolates 177833 and 178287, NDiV/LNV co-infected isolate 179853 and mock-infected cells. Gaps in the monolayer typical of NDiV/LNV infection are depicted by arrows for isolate 179853. Cell monolayer images were taken at 20x magnification. * Screened by RT-PCR with ABV-specific primers. The † LNV/NDiV-positive pool did not contain ABV. ‡ Ballina LNV/NDiV isolate originally reported in Prow et al. [<a href="#B28-viruses-12-01056" class="html-bibr">28</a>].</p>
Full article ">Figure 2
<p>Phylogenetic analysis of ABV VP1. Unrooted maximum likelihood trees constructed from (<b>a</b>) VP1 nucleotide coding sequences (CDS) aligned using the MUSCLE algorithm and (<b>b</b>) VP1 amino acid sequences aligned with MAFFT. The broad host-species classification for each virus is indicated by icons next to the virus name. Currently recognized genera are indicated in italics. Maximum likelihood analyses were performed in MEGA 7.0.26 using the general time-reversible (GTR) model with gamma distribution (5 categories ( + G, parameter = 1.8479)) and invariable variation for some sites ([ + I], 2.92% sites) for nucleotide sequences and the Jones–Taylor–Thornton (JTT) model with gamma substitutions and no deletions for amino acid sequences.</p>
Full article ">Figure 3
<p>Phylogenetic analysis of ABV polyprotein. Unrooted maximum likelihood trees constructed from (<b>a</b>) nucleotide coding sequences (CDS) for birnavirus polyproteins aligned using the MUSCLE algorithm and (<b>b</b>) polyprotein amino acid sequences aligned with MAFFT. The broad host-species classification for each virus is by icons next to the virus name. Currently recognized genera are indicated in italics. Maximum likelihood analyses were performed in MEGA 7.0.26 using the general time-reversible (GTR) model with gamma distribution (5 categories ( + G, parameter = 1.8479)) and invariable variation for some sites ([ + I], 2.92% sites) for nucleotide sequences and the Jones–Taylor–Thornton (JTT) model with gamma substitutions and no deletions for amino acid sequences.</p>
Full article ">Figure 4
<p>Protein analysis of ABV. (<b>a</b>) Transmission electron micrograph of purified ABV particles negatively stained with uranyl acetate and imaged at 200 K. Scale bar represents 100 nm. (<b>b</b>) Infectivity of two preparations of CsCl gradient-purified ABV particles in C6/36 cells as compared to ABV-infected cell supernatant used at a known MOI (0.1). Values graphed are averaged virus titers in supernatants taken from infected cells at 7 days post-infection (dpi). Error bars represent standard deviation in titers between 3 replicate wells. (<b>c</b>) Ruby stained image of SDS-PAGE analysis on purified ABV boiled and reduced with 1 M DTT, and results of mass spectrometry identification of excised protein bands as indicated by arrows. Protein ID refers to top ranking proteins identified in each band by mass spectrometry analysis. * No. peptides, number of peptides identified with equal to or greater than 50% confidence; <sup>†</sup> Coverage, percentage of protein covered by peptides identified with &gt;50% confidence. (<b>d</b>) Ruby stained image of SDS-PAGE analysis of ABV further denatured in 3 M urea. Protein identities based on mass spectrometry are indicated next to each band. Kaleidoscope protein ladder was run alongside all samples.</p>
Full article ">Figure 5
<p>Digestion of ABV proteins by trypsin and chymotrypsin. Schematic showing ABV polyprotein sequence identified by mass spectrometry following digestion with (<b>a</b>) trypsin or (<b>b</b>) chymotrypsin. Sequence detected by mass spectrometry is highlighted in grey and underlined. Colored bars above sequence denote predicted individual proteins: pVP2, magenta; VP4, green; VP3, black.</p>
Full article ">Figure 6
<p>Clustal W alignment of amino acid polyprotein sequences for ABV, RBV (CAX33877), IBDV (ANY27027), BSNV (CAD30689), ESV (AEW87521), DXV (NP_690836) and IPNV (NP_047196). Non-conserved insertions of 61 and 85 amino acids in the ABV polyprotein are indicated by red lines. Vertical lines in magenta depict published polyprotein cleavage sites for these birnaviruses [<a href="#B41-viruses-12-01056" class="html-bibr">41</a>,<a href="#B42-viruses-12-01056" class="html-bibr">42</a>]. ★ Denotes predicted cleavage sites for ABV based on mass spectrometry data; Molecular weights predicted using ExPASy compute pI/MW tool are marked at the c-terminus of each resulting protein. Green box, pVP2. Purple box, VP4; brown box, VP3.</p>
Full article ">Figure 7
<p>Antibody response to ABV. (<b>a</b>) Reactivity of anti-ABV mouse immune serum to ABV in Western blot. Lane 1, supernatant from ABV-infected C6/36 cells grown in minimal (&lt; 1%) FBS; 2, ABV virus stock supernatant from C6/36 cells, supplemented with 10% FBS; 3, CsCl gradient-purified preparation one of ABV in PBS; 4, CsCl gradient-purified preparation two of ABV in PBS. U, unreduced; BR, boiled and reduced. (<b>b</b>) Summary of ABV-specific monoclonal antibody panel. † Most likely target based on neutralizing activity. * Highest reciprocal dilution at which virus infectivity is inhibited. –, OD450 nm &lt;0.25 and less than two times the average OD of the negative control; +, OD450 nm is &gt;0.5 and at least two times greater than the average OD of negative control; +/-, positive result but inconsistent between replicates.</p>
Full article ">Figure 8
<p>ABV replication in mosquito cell lines. (<b>a</b>) IFA performed on mosquito cells infected with ABV or mock infected (media only) fixed with 4% formaldehyde (FA) and 0.5% Triton X-100 at 7 dpi and immunolabeled for dsRNA (green) and nuclei (blue). Main panel images taken at 40x and inset at 63x magnifications. (<b>b</b>) Mean titers in supernatants harvested from mosquito cells at 2 hpi (white) and 7 dpi (black). Error bars represent standard deviations between three replicates. Statistical significance was calculated by t tests using the Holm–Sidak method, with alpha = 0.05. Each row was analyzed individually, without assuming a consistent SD. ****, <span class="html-italic">p</span> &lt; 0.0001; *, <span class="html-italic">p</span> &lt; 0.05; ns, not significant. (<b>c</b>) Localization of dsRNA (red) in ABV-infected mosquito cells fixed with either 100% acetone, or 4% formaldehyde + 0.5% Triton X-100. DsRNA (red); nuclei (blue). Images taken at 63x magnification. (<b>d</b>) ABV or mock-infected mosquito cells stained with VP3- and VP2-specific mAbs. ABV protein (green); nuclei (blue). Images taken at 40x magnification. C6/36, RNAi-deficient <span class="html-italic">Ae. albopictus</span>; RML-12, RNAi-competent <span class="html-italic">Ae. albopictus</span>; Chao Ball, <span class="html-italic">Culex tarsalis</span>; Mos55, <span class="html-italic">Anopheles gambiae</span>.</p>
Full article ">
16 pages, 4373 KiB  
Article
The Epidemiological Signature of Pathogen Populations That Vary in the Relationship between Free-Living Parasite Survival and Virulence
by Lourdes M. Gomez, Victor A. Meszaros, Wendy C. Turner and C. Brandon Ogbunugafor
Viruses 2020, 12(9), 1055; https://doi.org/10.3390/v12091055 - 22 Sep 2020
Cited by 6 | Viewed by 4042
Abstract
The relationship between parasite virulence and transmission is a pillar of evolutionary theory that has implications for public health. Part of this canon involves the idea that virulence and free-living survival (a key component of transmission) may have different relationships in different host–parasite [...] Read more.
The relationship between parasite virulence and transmission is a pillar of evolutionary theory that has implications for public health. Part of this canon involves the idea that virulence and free-living survival (a key component of transmission) may have different relationships in different host–parasite systems. Most examinations of the evolution of virulence-transmission relationships—Theoretical or empirical in nature—Tend to focus on the evolution of virulence, with transmission being a secondary consideration. Even within transmission studies, the focus on free-living survival is a smaller subset, though recent studies have examined its importance in the ecology of infectious diseases. Few studies have examined the epidemic-scale consequences of variation in survival across different virulence–survival relationships. In this study, we utilize a mathematical model motivated by aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural history to investigate how evolutionary changes in survival may influence several aspects of disease dynamics at the epidemiological scale. Across virulence–survival relationships (where these traits are either positively or negatively correlated), we found that small changes (5% above and below the nominal value) in survival can have a meaningful effect on certain outbreak features, including R0, and on the size of the infectious peak in the population. These results highlight the importance of properly understanding the mechanistic relationship between virulence and parasite survival, as the evolution of increased survival across different relationships with virulence may have considerably different epidemiological signatures. Full article
(This article belongs to the Special Issue Virus Ecology and Evolution: Current Research and Future Directions)
Show Figures

Figure 1

Figure 1
<p>Compartmental diagram of the SEAIR-W (susceptible-exposed-asymptomatic-infected-recovered) version of a-WAIT (Waterborne Abiotic or other Indirect Transmission)) model: this is based on a previously developed mathematical model used to interrogate environmental transmission of SARS-CoV-2 (see [<a href="#B22-viruses-12-01055" class="html-bibr">22</a>]).</p>
Full article ">Figure 2
<p>Tornado plot showing the sensitivity of epidemic properties to individual parameter changes: (<b>A</b>) the number of infected individuals (asymptomatic and symptomatic) at the epidemic peak; (<b>B</b>) the rate at which the epidemic peak is reached, t<sub>max</sub><sup>−1</sup>; (<b>C</b>) the total infected population after 30 days; and (<b>D</b>) the basic reproductive ratio (<span class="html-italic">R</span><sub>0</sub>). Filled bars indicate the value of the epidemic feature when the associated parameter is increased by 5.0% from its nominal value. White bars indicate the value of a feature when the associated parameter is decreased by 5.0%. Blue coloring with checkered patterning indicates a parameter associated with survival, and orange coloring with lined patterning indicates a parameter associated with virulence.</p>
Full article ">Figure 3
<p>Sample dynamics for the model system: (<b>A</b>) the dynamics for all host compartments within the model and (<b>B</b>) the fraction of environmental reservoirs in a setting that are contaminated with infectious virus.</p>
Full article ">Figure 4
<p>Heatmap describing the impact of varying virus virulence and survival trait values assessed across four key epidemic metrics: these heatmaps express the change in (<b>A</b>) the number of infected individuals (asymptomatic and symptomatic) at the epidemic peak; (<b>B</b>) the rate at which the epidemic peak is reached, t<sub>max</sub><sup>−1</sup>; (<b>C</b>) the total infected population after 30 days; and (<b>D</b>) the basic reproductive ratio (<span class="html-italic">R</span><sub>0</sub>) when virulence and survival are modulated by ±5% within the model. Contour lines are available for clarity.</p>
Full article ">Figure 5
<p>The expected effect of increasing survival on virulence for the two correlation models considered: here, we present a schematic of how the different hypotheses for the relationship between virulence and survival manifest on a map with a structure similar to the heat maps shown in <a href="#viruses-12-01055-f004" class="html-fig">Figure 4</a>. The directions of the arrows depict how increasing survival would affect virulence under the two hypotheses: the blue arrow indicates the flow of an increasing positive correlation dynamic, while the direction of the orange arrow indicates an increasing negative correlation dynamic.</p>
Full article ">Figure 6
<p>The percent change in SEAIR-W outbreak metrics as survival increases from −5% to +5% for different virulence–survival relationships (positive correlation and negative correlation). For each metric analyzed, we present the percent difference between the minimum and maximum survival values given the two hypotheses tested: (i) positive correlation between survival and virulence (comparing low virulence/low survival to high virulence/high survival) and (ii) negative correlation (high virulence/low survival to high survival/low virulence). The bars here correspond to the values (percent) in the third columns of <a href="#viruses-12-01055-t005" class="html-table">Table 5</a> and <a href="#viruses-12-01055-t006" class="html-table">Table 6</a>, which denote the differences between the minimum and maximum values.</p>
Full article ">Figure 7
<p>Virus outbreak dynamics for the extreme values of virulence and free-living survival considered for the two different relationships (positive or negative) between virulence and survival traits: these plots are similar to the illustrative dynamics in <a href="#viruses-12-01055-f001" class="html-fig">Figure 1</a>. Here, we observe the dynamics of disease corresponding to the extreme values presented in <a href="#viruses-12-01055-t005" class="html-table">Table 5</a> and <a href="#viruses-12-01055-t006" class="html-table">Table 6</a>. Subfigures (<b>A</b>,<b>C</b>,<b>E</b>,<b>G</b>) depict disease dynamics, and (<b>B</b>,<b>D</b>,<b>F</b>,<b>H</b>) depict the dynamics of contaminated environments. (<b>A</b>–<b>D</b>) correspond to the parameter values considered for the positive correlation scenario, while (<b>E</b>–<b>H</b>) correspond to the negative correlation scenario.</p>
Full article ">
13 pages, 2477 KiB  
Article
Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus
by Entedar A. J. Alsaadi, Benjamin W. Neuman and Ian M. Jones
Viruses 2020, 12(9), 1054; https://doi.org/10.3390/v12091054 - 22 Sep 2020
Cited by 9 | Viewed by 5405
Abstract
Coronaviruses (CoVs) are enveloped, positive sense, single strand RNA viruses that cause respiratory, intestinal and neurological diseases in mammals and birds. Following replication, CoVs assemble on intracellular membranes including the endoplasmic reticulum Golgi intermediate compartment (ERGIC) where the envelope protein (E) functions in [...] Read more.
Coronaviruses (CoVs) are enveloped, positive sense, single strand RNA viruses that cause respiratory, intestinal and neurological diseases in mammals and birds. Following replication, CoVs assemble on intracellular membranes including the endoplasmic reticulum Golgi intermediate compartment (ERGIC) where the envelope protein (E) functions in virus assembly and release. In consequence, E potentially contains membrane-modifying peptides. To search for such peptides, the E coding sequence of Mouse Hepatitis Virus (MHV) was inspected for its amino acid conservation, proximity to the membrane and/or predicted amphipathic helices. Peptides identified in silico were synthesized and tested for membrane-modifying activity in the presence of giant unilamellar vesicles (GUVs) consisting of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), sphingomyelin and cholesterol. To confirm the presence of membrane binding peptides identified in the context of a full-length E protein, the wild type and a number of mutants in the putative membrane binding peptide were expressed in Lenti-X-293T mammalian and insect cells, and the distribution of E antigen within the expressing cell was assessed. Our data identify a role for the post-transmembrane region of MHV E in membrane binding. Full article
(This article belongs to the Collection Coronaviruses)
Show Figures

Figure 1

Figure 1
<p>Multiple sequence alignment of coronavirus E protein. Alignment was done using Jalview 2.9.0b2 and the position of key features, TM, EPTM, Cys region and conserved prolines indicated. Four genera of coronavirus are represented as follows: α-CoV is represented by HCOV-229E, Human coronavirus 229E (NP_073554.1); M-BatCoV-HKU8, Miniopterus bat coronavirus Hong Kong University 8 (YP_001718614.1); TGEV-Purdue, transmissible gastroenteritis virus- Purdue (ABG89336.1); HCoV-NL63, Human coronavirus NL63 (YP_003769.1); PEDV, Porcine epidemic diarrhea virus (NP_598312.1); FCoV, Feline coronavirus (YP_004070197.1); β-CoV include HCoV-HKU1, Human coronavirus Hong Kong University 1(YP_173240.1); MHV-A59, Murine hepatitis virus-A59 (NP_068673.1); SARS-CoV, Severe acute respiratory syndrome coronavirus (NP_828854.1); MERS-CoV, Middle East respiratory syndrome coronavirus (YP_009047209.1); BCoV-HKU9, Bat coronavirus Hong Kong University 9 (YP_001039973.1); γ-CoV include IBV, Infectious bronchitis virus (ADP06512.1); SW1, sperm Whale coronavirus 1(YP_001876438.1); BdCoV-HKU22, Bottlenose dolphin coronavirus Hong Kong University 22 (AHB63482.1); δ-CoV consists of NHCoV-HKU19, Night-heron-coronavirus- Hong Kong University 19 (AFD29227.1); PD-CoV, Porcine coronavirus Hong Kong University 15 (YP_005352832.1); MCoV-HKU13, Munia coronavirus Hong Kong University 13-3514(YP_002308507.1). TM: transmembrane domain; highly conserved cysteine residues indicated; conserved proline indicated by stars. Blue represents hydrophobic amino acids (A, I, L, M, F, W, V); Red represents positive charge amino acids (K, R); Magenta represents negative charge amino acids (E, D); Green represents polar amino acids (N, Q, S, T); Pink represents cysteines (C); Orange represents glycines (G); Yellow represents prolines (P); Cyan represents aromatic amino acids (H, Y); White represents any unconserved/gap. The SARS-CoV-2 E protein is 95% identical to SARS E, so was not included as a distinct entry.</p>
Full article ">Figure 2
<p>Effect of MHV E protein-derived peptides on size and shape of GUVs. (<b>A</b>) Fluorescent images of electroformed GUVs treated with peptides MHV-EPTM, MHV-ETM and M2-Infleunza and imaged at 0, 1, 2 and 5 min postaddition. (<b>B</b>) GUV relative size estimated by Ramanujan’s first approximation. Then standard deviation for both long and short measurements for a vesicle was also measured and averaged for each GUV for three separate experiments of 40 GUVs each. (<b>C</b>) GUV shape, measured as the ratio between the longest and shortest radii and averaged for each GUV for three separate experiments of 40 GUVs each. The scale bar indicates 20 µm. Error bars shown are mean ± SEM. The stars *** indicate significance (<span class="html-italic">p</span> ≤ 0.001; with respect to the corresponding buffer; Linear Mixed). Each coloured group of four columns represents the data for a single peptide test at each time point. Left to right, 0, 1, 2 and 5 min. Some error bars are too small to be observed.</p>
Full article ">Figure 3
<p>Immunofluorescent staining of MHV E protein expression in Lenti-X 293T cells. (<b>A</b>) Cells were transfected with pTriEx1.1 vectors encoding WT MHV-CoV E or various alanine mutants, fixed and permeabilized and detected with anti-His Ab conjugated to Alexa Flour 488 (green). Nuclei were counterstained with DAPI (blue). Punctate staining is indicated. (<b>B</b>) Enlarged images of the WT and L52A panels with punctate staining indicated. In both panels the scale bar is 20 M.</p>
Full article ">Figure 4
<p>Western blot analysis of WT MHV-E protein expression and mutants following expression in insect cells. (<b>A</b>) Western blot using anti-His antibody. Lane M - See Blue™ Plus2 Pre-Stained Protein Standard (Invitrogen). Lanes 1-11 are samples as follows: 1: WT E, 2: L50A, 3: V51A, 4: L52A, 5: P54A, 6: Y57A, 7: Y59A, 8: all mutants, 9: deleted EPTM, 10: GFP baculovirus (positive control), 11: mock. (<b>B</b>) Western blot by anti baculovirus surface glycoprotein gp64 following stripping of the membrane used for panel A Key molecular mass markers are indicated to the left of each panel.</p>
Full article ">Figure 5
<p>Western blot Analysis of WT MHV-E and mutants following membrane partition by differential centrifugation. (<b>A</b>) Detection of E protein by anti-His antibody in the low- and high-speed membrane fractions (marked). Lane M - See Blue™ Plus2 Pre-Stained Protein Standard (Invitrogen) with 14KDa marker identified. Lanes 1-9 are samples as follows: 1: WT E, 2: L50A, 3: V51A, 4: L52A, 5: P54A, 6: Y57A, 7: Y59A, 8: all mutants, 9: deleted EPTM. The single panel to the right of panel <b>A,</b> marked <b>C,</b> is the LSP and HSP fractions blotted with an antibody to calnexin. (<b>B</b>) The altered distribution of E, dependent on its sequence, is evident by the relative band intensity and was measured by ImageJ densitometry. The filled bars are the LSP samples, the open bars the HSP.</p>
Full article ">Figure 6
<p>Predicted topological models of E and the EPTM peptide. <b>Above</b>: Two of the suggested topologies of E are shown with TM, N- and C-termini indicated. <b>Middle</b>: The EPTM peptide is shown within the C-terminal region. Mutated residues are enlarged and coloured according to the level of membrane repartitioning observed. <b>Below</b>: A helical wheel depiction of the EPTM peptide with a suggested interpretation of sidedness with respect to membrane attachment.</p>
Full article ">
18 pages, 4696 KiB  
Review
Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure
by Nicholas C. Wu and Ian A. Wilson
Viruses 2020, 12(9), 1053; https://doi.org/10.3390/v12091053 - 22 Sep 2020
Cited by 39 | Viewed by 7656
Abstract
Hemagglutinin (HA) glycoprotein is an important focus of influenza research due to its role in antigenic drift and shift, as well as its receptor binding and membrane fusion functions, which are indispensable for viral entry. Over the past four decades, X-ray crystallography has [...] Read more.
Hemagglutinin (HA) glycoprotein is an important focus of influenza research due to its role in antigenic drift and shift, as well as its receptor binding and membrane fusion functions, which are indispensable for viral entry. Over the past four decades, X-ray crystallography has greatly facilitated our understanding of HA receptor binding, membrane fusion, and antigenicity. The recent advances in cryo-EM have further deepened our comprehension of HA biology. Since influenza HA constantly evolves in natural circulating strains, there are always new questions to be answered. The incessant accumulation of knowledge on the structural biology of HA over several decades has also facilitated the design and development of novel therapeutics and vaccines. This review describes the current status of the field of HA structural biology, how we got here, and what the next steps might be. Full article
(This article belongs to the Special Issue In Memory of Michael Rossmann)
Show Figures

Figure 1

Figure 1
<p>Natural evolution of receptor-binding mode in seasonal influenza virus. Crystal structures of human receptor analog (6′-SLNLN, yellow) in complex with HAs from two human H3N2 influenza strains that were isolated 40 years apart, namely A/Hong Kong/1/1968 (cyan) and A/Brisbane/10/2007 (pink), are shown. Representative residues in the receptor binding site (RBS) that were mutated during the course of natural evolution are shown in stick representations. Hydrogen bonds are shown as dashed lines. All structure images in this review were rendered by PyMOL (<a href="http://www.pymol.org" target="_blank">www.pymol.org</a>).</p>
Full article ">Figure 2
<p>Conformational change of HA during pH-induced membrane fusion. Different intermediates states of HA during pH-induced conformational change were identified by cryo-EM [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>]. The top and side views of state 1 (prefusion conformation, PDB 6Y5H) [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>], state 2 (dilated form 1, PDB 6Y5I) [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>], state 3 (dilated form 2, PDB 6Y5J) [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>], state 4 (extended HA2, PDB 6Y5K) [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>], and state 5 (post-fusion conformation, PDB 1QU1) are shown [<a href="#B61-viruses-12-01053" class="html-bibr">61</a>]. Of note, after fusion peptide is released from state 2, the fusion peptide becomes disordered [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>]. In state 3, the membrane proximal region (yellow) is also disordered [<a href="#B60-viruses-12-01053" class="html-bibr">60</a>]. Different components in the HA2 that are involved in structural rearrangements between pre- and post-fusion structures are in different colors.</p>
Full article ">Figure 3
<p>Conventional antigenic sites and recently identified epitopes. (<b>A</b>) The five major antigenic sites A-E on H3N2 HA are shown. (<b>B</b>) There is an accumulation of glycosylation sites during human H3N2 evolution. While many antigenic sites have now been masked by glycans (yellow), antigenic site B (blue) remains exposed due to its proximity to the RBS, making it immunodominant in recent human H3N2 strains [<a href="#B95-viruses-12-01053" class="html-bibr">95</a>,<a href="#B96-viruses-12-01053" class="html-bibr">96</a>]. (<b>C</b>) Broadly neutralizing epitopes that have been identified in the past decade are shown. (<b>D</b>) A recently identified trimeric interface epitope is illustrated.</p>
Full article ">
16 pages, 3728 KiB  
Article
Characterization of PlyB221 and PlyP32, Two Novel Endolysins Encoded by Phages Preying on the Bacillus cereus Group
by Audrey Leprince, Manon Nuytten, Annika Gillis and Jacques Mahillon
Viruses 2020, 12(9), 1052; https://doi.org/10.3390/v12091052 - 21 Sep 2020
Cited by 14 | Viewed by 3800
Abstract
Endolysins are phage-encoded enzymes implicated in the breaching of the bacterial cell wall at the end of the viral cycle. This study focuses on the endolysins of Deep-Blue (PlyB221) and Deep-Purple (PlyP32), two phages preying on the Bacillus cereus group. Both enzymes exhibit [...] Read more.
Endolysins are phage-encoded enzymes implicated in the breaching of the bacterial cell wall at the end of the viral cycle. This study focuses on the endolysins of Deep-Blue (PlyB221) and Deep-Purple (PlyP32), two phages preying on the Bacillus cereus group. Both enzymes exhibit a typical modular organization with an enzymatically active domain (EAD) located in the N-terminal and a cell wall binding domain (CBD) in the C-terminal part of the protein. In silico analysis indicated that the EAD domains of PlyB221 and PlyP32 are endowed with peptidase and muramidase activities, respectively, whereas in both proteins SH3 domains are involved in the CBD. To evaluate their antimicrobial properties and binding specificity, both endolysins were expressed and purified. PlyB221 and PlyP32 efficiently recognized and lysed all the tested strains from the B. cereus group. Biochemical characterization showed that PlyB221 activity was stable under a wide range of pHs (5–9), NaCl concentrations (up to 200 mM), and temperature treatments (up to 50 °C). Although PlyP32 activity was less stable than that of PlyB221, the endolysin displayed high activity at pH 6–7, NaCl concentration up to 100 mM and the temperature treatment up to 45 °C. Overall, PlyB221 and PlyP32 display suitable characteristics for the development of biocontrol and detection tools. Full article
(This article belongs to the Section Bacterial Viruses)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>In silico analysis of Deep-Blue PlyB221 and Deep-Purple PlyP32. (<b>A</b>) PlyB221 two domain organization. The EAD is a putative L-Ala-D-Glu peptidase domain (superfamily Peptidase_M15) and the CBD contains two potential SH3 domains (superfamily SH3). (<b>B</b>) PlyP32 displays a GH25_PlyB_like domain as EAD (GH25 superfamily) characteristic of a muramidase activity and a single SH3 domain as CBD.</p>
Full article ">Figure 2
<p>Multiple sequence alignment of PlyB221, PlyP32, and related endolysins. (<b>A</b>) Multiple sequence alignment of PlyB221 with endolysins from phages BigBertha, B4 (LysB4), and Phrodo (PlyP56). (<b>B</b>) Multiple sequence alignment of PlyP32 with endolysins from phages Bcp1 (PlyB) and BtCS33 (PlyBt33). Residues considered as participating to the active sites are highlighted by red frames, while red stars indicate the Zn<sup>2+</sup> binding sites in PlyB221. The putative EAD region is underlined in blue, the ‘linker’ sequence with a dashed red line and the CBD in orange.</p>
Full article ">Figure 3
<p>Dendrogram of relationships between the characterized endolysins of <span class="html-italic">B. cereus</span> phages. The tree was built using the maximum likelihood method and JTT matrix-based model with 100 bootstrap iterations. Endolysins are indicated by the name of the phage they derived from. Endolysins with the same EAD are grouped in the same cluster. Muramidases, amidases, and endopeptidases are highlighted as yellow, blue, and gray rectangles, respectively. Deep-Blue and Deep-Purple endolysins are indicated by red asterisks. The bar indicates 0.5 substitutions per amino acid site. The numbers refer to the percentage of trees in which the associated endolysins clustered together.</p>
Full article ">Figure 4
<p>SDS-page gel of purified endolysins PlyB221 and PlyP32. The recombinant proteins were expressed in <span class="html-italic">E. coli</span> BL21(DE3) and purified thanks to a six-histidine tag on a Ni-NTA column. Lane 1: Protein ladder in kDa; Lane 2: PlyB221; Lane 3: PlyP32; Lane 4: GFP::PlyB221_CBD; Lane 5: GFP::PlyP32_CBD.</p>
Full article ">Figure 5
<p>Bacteriolytic activity of PlyB221 (<b>A</b>) and PlyP32 (<b>B</b>) assessed by OD monitoring. The activity test was performed on exponentially growing <span class="html-italic">B. cereus</span> ATCC 10,987 at 30 °C in the optimal buffer for each endolysin and using enzyme concentrations ranging from 3 to 100 µg/mL.</p>
Full article ">Figure 6
<p>PlyB221 activity on purified cell wall extracts. Cell wall extracts from <span class="html-italic">B. cereus</span> ATCC 10,987 were purified and mixed by PlyB221. (<b>A</b>) Macroscopic observation <span class="html-italic">of B. cereus</span> cell wall hydrolysis with 100 µg of endolysin after 10 min at RT. (<b>B</b>) OD<sub>595</sub> monitoring during 30 min (30 °C) of cell wall hydrolysis using endolysin concentrations ranging from 1 to 100 µg/mL.</p>
Full article ">Figure 7
<p>Biochemical characterization of PlyB221 and PlyP32. Exponentially growing <span class="html-italic">B. cereus</span> ATCC 10,987 cells were resuspended in buffer of various pH (<b>A</b>,<b>B</b>) and NaCl concentration (<b>C</b>,<b>D</b>) and challenged with 50 µg/mL of protein during 30 min to assess the endolysins optimal activity. PlyB221 and PlyP32 stability to temperature (<b>E</b>,<b>F</b>) was tested by incubating the proteins (50 µg/mL) at given temperatures during 30 min and transferred for 5 min on ice. The experiments were done in triplicate. Stars indicate significant differences (Student’s <span class="html-italic">t</span>-test, <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 8
<p>Binding ability of PlyB221 and PlyP32 CBD. Exponentially growing cultures were used in a cell wall decoration assay based on the observation of the GFP fused CBD adsorbed to bacteria by fluorescent microscopy. Images on the left show bright field microscopy while images on the right display the corresponding fluorescent images. (<b>A</b>,<b>B</b>) <span class="html-italic">B. cereus</span> ATCC 10,987 - PlyB221_CBD; (<b>C</b>,<b>D</b>). <span class="html-italic">B. weihenstephanensis</span> Si0239 - PlyB221_CBD; (<b>E</b>,<b>F</b>) <span class="html-italic">B. megaterium</span> Si0003 - PlyP32_CBD; (<b>G</b>,<b>H</b>) <span class="html-italic">B. weihenstephanensis</span> LH002 - PlyP32_CBD. Scale bar = 25 µm for all panels.</p>
Full article ">
23 pages, 704 KiB  
Review
Immune Checkpoints in Viral Infections
by Huiming Cai, Ge Liu, Jianfeng Zhong, Kai Zheng, Haitao Xiao, Chenyang Li, Xun Song, Ying Li, Chenshu Xu, Haiqiang Wu, Zhendan He and Qinchang Zhu
Viruses 2020, 12(9), 1051; https://doi.org/10.3390/v12091051 - 21 Sep 2020
Cited by 45 | Viewed by 4803
Abstract
As evidence has mounted that virus-infected cells, such as cancer cells, negatively regulate the function of T-cells via immune checkpoints, it has become increasingly clear that viral infections similarly exploit immune checkpoints as an immune system escape mechanism. Although immune checkpoint therapy has [...] Read more.
As evidence has mounted that virus-infected cells, such as cancer cells, negatively regulate the function of T-cells via immune checkpoints, it has become increasingly clear that viral infections similarly exploit immune checkpoints as an immune system escape mechanism. Although immune checkpoint therapy has been successfully used in cancer treatment, numerous studies have suggested that such therapy may also be highly relevant for treating viral infection, especially chronic viral infections. However, it has not yet been applied in this manner. Here, we reviewed recent findings regarding immune checkpoints in viral infections, including COVID-19, and discussed the role of immune checkpoints in different viral infections, as well as the potential for applying immune checkpoint blockades as antiviral therapy. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Figure 1
<p>Mechanism of immune checkpoint-mediated T-cell inactivation. ①: PD-1/PD-L1 inhibits the PI3K/AKT pathway or ZAP70 phosphorylation by recruiting SHP2 phosphatase; ②: CTLA-4 competitively binds to the B7 ligand of CD28 and directly inhibits Akt by activating the phosphatase PP2A, and induces proapoptotic protein BIM; ③: TIM-3/Gal-9 releases Bat3, the molecule that binds to the intracellular tail of Tim-3, which allows Tim3 to bind to Lck or PLC-γ, leading to NF-κB and NFAT inhibition; ④: BTLA/HVEM recruits SHP-1, leading to the inhibition of LCK-dependent T-cell activation; ⑤: TIGIT/CD155 directly inhibits T-cell activation and proliferation by countering the costimulatory function of CD226, and also inhibits PI3K and MAPK signaling pathway by recruiting SHIP-1; ⑥: Lag-3 downregulates T-cell activation through a still unclear mechanism. Abbreviations: ITAMs, immunoreceptor tyrosine-based activation motif l; LCK, lymphocyte-specific protein tyrosine kinase; ZAP70, zeta chain of T-cell receptor associated protein kinase 70; PLC-γ, Phospholipase C-γ; PI3K, phosphatidylinositol 3-kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PIP2, phosphatidyl inositol(4,5) bisphosphate; IP3, inositol-1,4,5-trisphosphate; DAG, diacylglycerol; PKC, protein kinase C; CaN, Calcineurin; IKK, inhibitor of nuclear factor kappa-B kinase; Akt, protein kinase B (Also known as PKB or Rac); PP2A, Protein phosphatase 2 A; Ras/MEK/MAPK, Ras GTPase-protein/MAP kinase kinase/MAP kinase pathway; mTORC1, mammalian target of rapamycin complex 1; NFAT, nuclear factor of activated T-cells; pNFAT, phospho NFAT; AP-1, activator protein 1; NF-κB, nuclear factor-κB.</p>
Full article ">
15 pages, 3376 KiB  
Article
Metagenomic Insights into the Sewage RNA Virosphere of a Large City
by Sergio Guajardo-Leiva, Jonás Chnaiderman, Aldo Gaggero and Beatriz Díez
Viruses 2020, 12(9), 1050; https://doi.org/10.3390/v12091050 - 21 Sep 2020
Cited by 25 | Viewed by 5084
Abstract
Sewage-associated viruses can cause several human and animal diseases, such as gastroenteritis, hepatitis, and respiratory infections. Therefore, their detection in wastewater can reflect current infections within the source population. To date, no viral study has been performed using the sewage of any large [...] Read more.
Sewage-associated viruses can cause several human and animal diseases, such as gastroenteritis, hepatitis, and respiratory infections. Therefore, their detection in wastewater can reflect current infections within the source population. To date, no viral study has been performed using the sewage of any large South American city. In this study, we used viral metagenomics to obtain a single sample snapshot of the RNA virosphere in the wastewater from Santiago de Chile, the seventh largest city in the Americas. Despite the overrepresentation of dsRNA viruses, our results show that Santiago’s sewage RNA virosphere was composed mostly of unknown sequences (88%), while known viral sequences were dominated by viruses that infect bacteria (60%), invertebrates (37%) and humans (2.4%). Interestingly, we discovered three novel genogroups within the Picobirnaviridae family that can fill major gaps in this taxa’s evolutionary history. We also demonstrated the dominance of emerging Rotavirus genotypes, such as G8 and G6, that have displaced other classical genotypes, which is consistent with recent clinical reports. This study supports the usefulness of sewage viral metagenomics for public health surveillance. Moreover, it demonstrates the need to monitor the viral component during the wastewater treatment and recycling process, where this virome can constitute a reservoir of human pathogens. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Map of el Trebal Wastewater Treatment Plant location in Santiago de Chile. El Trebal wastewater treatment plant (WWTP) is indicated by a white-star red baloon.</p>
Full article ">Figure 2
<p>Relative abundances of predicted protein sequences in Trebal viral RNA metagenome, classified by LCA algorithm trough local alignment to NCBI nr database. (<b>A</b>) Domain level, and (<b>B</b>) Family level for sequences classified as Virus in A. (<b>C</b>) Putative host for sequences classified as Virus in A. Sequences were normalized by protein length.</p>
Full article ">Figure 3
<p>Hierarchical clustering analysis of 2266 RNA-dependent RNA polymerase (RdRP) predicted protein sequences from Trebal and NCBI RefSeq database based on Bray–Curtis amino acid distance (<span class="html-italic">k</span> = 2). Dendrogram was divided in 12 main cluster based on the “unrooted” dendrogram. Pie charts represent the frequency of sequences in each cluster classified by the putative host trough LCA algorithm. Bar charts represent the source (NCBI or Trebal) from which sequences were retrieved inside each cluster.</p>
Full article ">Figure 4
<p>Maximum Likelihood phylogenetic reconstruction of 31 RNA-dependent RNA polymerase (RdRP) predicted proteins from <span class="html-italic">Picobirnaviridae</span> family. Node numbers indicate ultra-fast bootstrap values. RdRP sequence of White clover cryptic virus 1 was used as an outgroup and appeared in grey letters. The sequences characterized in the present study are reported in red letters. Scale bar: 0.5 aminoacid substitution per site.</p>
Full article ">Figure 5
<p>Relative abundances of Human <span class="html-italic">Rotavirus</span> species and genotypes inferred from Pfam annotated VP4, VP6, and VP7 genes and classified by local alignment (BLASTn) to NCBI nt database. Sequences were normalized by gene length. (<b>A</b>) Relative abundance of Human <span class="html-italic">Rotavirus</span> species based on VP6. (<b>B</b>) Relative abundance of Human <span class="html-italic">Rotavirus</span> G types based on VP7. (<b>C</b>) Relative abundance of Human <span class="html-italic">Rotavirus</span> P types based on VP4.</p>
Full article ">
3 pages, 140 KiB  
Editorial
Special Issue: “Plant Virus Pathogenesis and Disease Control”
by Bryce W. Falk and Shahideh Nouri
Viruses 2020, 12(9), 1049; https://doi.org/10.3390/v12091049 - 21 Sep 2020
Cited by 3 | Viewed by 4190
Abstract
Plant viruses are emerging and re-emerging to cause important diseases in many plants that humans grow for food and/or fiber, and sustainable, effective strategies for controlling many plant virus diseases remain unavailable [...] Full article
(This article belongs to the Special Issue Plant Virus Pathogenesis and Disease Control)
13 pages, 10351 KiB  
Brief Report
The Emergence of a vv + MDV Can Break through the Protections Provided by the Current Vaccines
by Meng-ya Shi, Min Li, Wei-wei Wang, Qiao-mu Deng, Qiu-hong Li, Yan-li Gao, Pei-kun Wang, Teng Huang and Ping Wei
Viruses 2020, 12(9), 1048; https://doi.org/10.3390/v12091048 - 20 Sep 2020
Cited by 21 | Viewed by 3909
Abstract
Marek’s disease (MD) is an infectious malignant T-cell lymphoma proliferative disease caused by Marek’s disease virus (MDV). In recent years, the emergence of very virulent (vv) and/or very virulent plus (vv +) strains of MDV in the field has been suggested as one [...] Read more.
Marek’s disease (MD) is an infectious malignant T-cell lymphoma proliferative disease caused by Marek’s disease virus (MDV). In recent years, the emergence of very virulent (vv) and/or very virulent plus (vv +) strains of MDV in the field has been suggested as one of the causes of vaccination failure. The pathogenicity of the MDV strain GX18NNM4, isolated from a clinical outbreak in a broiler breeder flock that was vaccinated with CVI988/Rispens, was investigated. In the vaccination-challenge test, GX18NNM4 was able to break through the protections provided by the vaccines CVI988 and 814. It also significantly reduced body weight gain and caused marked gross lesions and a large area of infiltration of neoplastic lymphocyte cells in the heart, liver, pancreas, etc. of the infected birds. In addition, the expressions of programmed death 1 (PD-1) and its ligand, programmed death ligand 1 (PD-L1), in the spleens and cecal tonsils (CTs) of the unvaccinated challenged birds were significantly increased compared to those in the vaccinated challenged birds, indicating that the PD-1/PD-L1 pathway is related to immune evasion mechanisms. The results showed that the GX18NNM4 strain could cause severe immunosuppression and significantly decrease the protections provided by the current commercial vaccines, thus showing GX18NNM4 to be a vv + MDV strain. Full article
(This article belongs to the Special Issue Animal Herpesviruses Pathogenesis and Immunity)
Show Figures

Figure 1

Figure 1
<p>Statistics of body weight of experimental birds (X ± SD). Means not sharing a common letter are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 2
<p>Dynamics of immune organ indices of the experimental birds. (<b>A</b>) spleen; (<b>B</b>) thymus; (<b>C</b>) bursa. Means not sharing a common letter are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>The viral load of MDV in the peripheral blood lymphocytes (PBLs) of the experimental birds. Means not sharing a common letter are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>The mRNA expressions of PD-1 and PD-L1 in the tissues from birds experimentally infected with MDV. (<b>A</b>) PD-1 in the spleen; (<b>B</b>) PD-1 in the cecal tonsils; (<b>C</b>) PD-L1 in the spleen; (<b>D</b>) PD-L1 in the cecal tonsils. Determined by real-time PCR. Means not sharing a common letter are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Survival patterns showing the overall effects of the various treatments.</p>
Full article ">Figure 6
<p>Anatomical and histological lesions: (<b>A</b>,<b>L</b>) white solid nodules in the lungs; (<b>E</b>,<b>P</b>) numerous proliferating tumor cells concentrated in the lung tissue; (<b>B</b>,<b>D</b>,<b>J</b>) tumor or tumor-like lesions in the heart; (<b>F</b>,<b>H</b>,<b>N</b>) numerous infiltrations of diffuse lymphocytosis in myocardial fibers; (<b>C</b>) pancreas hemorrhage with tumor; (<b>G</b>) numerous lymphocytosis proliferations in pancreas; (<b>I</b>) white tumor nodules, approximately 1–3 mm in diameter, on the liver surface; (<b>M</b>) numerous proliferating tumor cells were concentrated in the hepatic tissue; (<b>K</b>) white tumor nodule on the surface of spleen; (<b>O</b>) large number of lymphocytes infiltrated in the spleen tissue.</p>
Full article ">
15 pages, 897 KiB  
Article
Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015–19
by Elisa Zanotto, Anna Allesina, Antonella Barreca, Francesca Sidoti, Ester Gallo, Paolo Bottino, Marco Iannaccone, Gabriele Bianco, Luigi Biancone, Rossana Cavallo and Cristina Costa
Viruses 2020, 12(9), 1047; https://doi.org/10.3390/v12091047 - 20 Sep 2020
Cited by 6 | Viewed by 3143
Abstract
Background: In kidney transplant patients, polyomavirus-associated nephropathy (PVAN) represents a serious complication; the key factor for the development of PVAN is immunosuppression level and modulation of anti-rejection treatment represents the first line of intervention. Allograft biopsy and histology remain the criterion standard for [...] Read more.
Background: In kidney transplant patients, polyomavirus-associated nephropathy (PVAN) represents a serious complication; the key factor for the development of PVAN is immunosuppression level and modulation of anti-rejection treatment represents the first line of intervention. Allograft biopsy and histology remain the criterion standard for diagnosing PVAN. Methods: All consecutive renal biopsies with the diagnosis of PVAN carried out at the University Hospital City of Health and Science of Turin over a five-years period were studied. Renal allograft biopsy was performed due to renal function alterations associated to medium-high polyomavirus BK (BKV)-DNA levels on plasma specimen. Results: A total of 21 patients underwent a first biopsy to diagnose a possible BKV nephropathy, in 18, a second biopsy was made, in eight, a third biopsy, and finally, three underwent the fourth renal biopsy; following the results of each biopsies, immunosuppressant agents dosages were modified in order to reduce the effect of PVAN. Conclusions: In this study, the clinical and histological features of 21 kidney transplant recipients with BKV reactivation and development of PVAN are described. To date, the only treatment for PVAN consists in the reduction of immunosuppressive agents, constantly monitoring viral load. Full article
(This article belongs to the Special Issue BK Virus and Transplantation)
Show Figures

Figure 1

Figure 1
<p>Renal biopsy (RB) and concomitant viral load (expressed as Log<sub>10</sub> copies/mL). Number of biopsies for each patient: first biopsy in 21 patients, second in 18, third in eight and fourth in three.</p>
Full article ">Figure 2
<p>Histological results and polyomavirus nephropathy (PVAN) staging at renal biopsies. Tx list, entry in transplant list; HD, hemodialysis.</p>
Full article ">
19 pages, 2736 KiB  
Article
PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems
by Ahmed Mostafa, Sara H. Mahmoud, Mahmoud Shehata, Christin Müller, Ahmed Kandeil, Rabeh El-Shesheny, Hanaa Z. Nooh, Ghazi Kayali, Mohamed A. Ali and Stephan Pleschka
Viruses 2020, 12(9), 1046; https://doi.org/10.3390/v12091046 - 20 Sep 2020
Cited by 14 | Viewed by 4530
Abstract
Egypt is a hotspot for H5- and H9-subtype avian influenza A virus (AIV) infections and co-infections in poultry by both subtypes have been frequently reported. However, natural genetic reassortment of these subtypes has not been reported yet. Here, we evaluated the genetic compatibility [...] Read more.
Egypt is a hotspot for H5- and H9-subtype avian influenza A virus (AIV) infections and co-infections in poultry by both subtypes have been frequently reported. However, natural genetic reassortment of these subtypes has not been reported yet. Here, we evaluated the genetic compatibility and replication efficiency of reassortants between recent isolates of an Egyptian H5N1 and a H9N2 AIV (H5N1EGY and H9N2EGY). All internal viral proteins-encoding segments of the contemporaneous G1-like H9N2EGY, expressed individually and in combination in the genetic background of H5N1EGY, were genetically compatible with the other H5N1EGY segments. At 37 °C the replication efficiencies of H5N1EGY reassortants expressing the H9N2EGY polymerase subunits PB2 and PA (H5N1PB2-H9N2EGY, H5N1PA-H9N2EGY) were higher than the wild-type H5N1EGY in Madin-Darby canine kidney (MDCK-II) cells. This could not be correlated to viral polymerase activity as this was found to be improved for H5N1PB2-H9N2EGY, but reduced for H5N1PA-H9N2EGY. At 33 °C and 39 °C, H5N1PB2-H9N2EGY and H5N1PA-H9N2EGY replicated to higher levels than the wild-type H5N1EGY in human Calu-3 and A549 cell lines. Nevertheless, in BALB/c mice both reassortants caused reduced mortality compared to the wild-type H5N1EGY. Genetic analysis of the polymerase-encoding segments revealed that the PAH9N2EGY and PB2H9N2EGY encode for a distinct uncharacterized mammalian-like variation (367K) and a well-known mammalian signature (591K), respectively. Introducing the single substitution 367K into the PA of H5N1EGY enabled the mutant virus H5N1PA-R367K to replicate more efficiently at 37 °C in primary human bronchial epithelial (NHBE) cells and also in A549 and Calu-3 cells at 33 °C and 39 °C. Furthermore, H5N1PA-R367K caused higher mortality in BALB/c mice. These findings demonstrate that H5N1 (Clade 2.2.1.2) reassortants carrying internal proteins-encoding segments of G1-like H9N2 viruses can emerge and may gain improved replication fitness. Thereby such H5N1/H9N2 reassortants could augment the zoonotic potential of H5N1 viruses, especially by acquiring unique mammalian-like aa signatures. Full article
(This article belongs to the Special Issue Evolution and Pathogenesis of Avian and Animal Influenza Viruses)
Show Figures

Figure 1

Figure 1
<p>Genetic compatibility between Egyptian H5N1- and H9N2-viruses. The six internal-proteins encoding segments of LPAIV H9N2<sub>EGY</sub>, were placed individually and in combination, into the genetic background of HPAIV H5N1<sub>EGY</sub>. The gene segments from H5N1<sub>EGY</sub> and H9N2<sub>EGY</sub> are colored in grey and red, respectively. The six internal-proteins encoding segments from H7N9<sub>Anhui</sub> (control) are colored in green. All genetic constellations used in this study were transfected to co-culture of 293T/MDCK-II cells and the rescued wild-type, reassortant and mutant viruses were propagated on embryonated SPF eggs. All genetic combinations were compatible showing variable hemagglutination unit (HAU) and focus forming unit (FFU) titers.</p>
Full article ">Figure 2
<p>Replication efficiency of the H5N1<sub>EGY</sub> reassortants. Mammalian Madin-Darby canine kidney (MDCK-II) cells were infected (in triplicate) with H5N1<sub>EGY</sub> reassortants expressing internal proteins-encoding H9N2<sub>EGY</sub> genes or with the wild-type H5N1<sub>EGY</sub> or the control H5N1<sub>6H7N9Anhui</sub> virus at MOI of 0.01, cultured at 37 °C for single replication cycle (8 h) and multiple replication cycles (24 h) p.i. Subsequently the virus titers were determined. Error bars reflect standard deviation (SD) of three independent experiments. Statistical analysis was performed using repeated measures ANOVA, followed by Bonferroni post hoc test. The significant differences are indicated (** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001 and non-significant = ns).</p>
Full article ">Figure 3
<p>In vitro polymerase activity in human 293T cells. 293T cells were transfected with plasmids expressing the three subunits (PB2, PB1, and PA) of the viral RNA-dependent RNA polymerase (RdRp) and the viral nucleoprotein (NP) of H5N1<sub>EGY</sub>, H9N2<sub>EGY,</sub> H7N9<sub>Anhui</sub> or combinations of H5N1<sub>EGY</sub> RdRp subunits with single RdRp subunits of H9N2<sub>EGY</sub>. Along with the three RdRp subunits and NP expressing plasmids, a vector expressing a vRNA-like Pol-1 transcript encoding the reporter GFP gene was co-transfected. At 48 h p.t., the control and the transfected cells were analyzed for percentage of GFP positive cells. The significance was tested using one-way ANOVA, followed by Dunnett’s multiple comparison post hoc test and the significant differences are indicated (* = <span class="html-italic">p</span> &lt; 0.05, *** = <span class="html-italic">p</span> &lt; 0.001 and non-significant = ns).</p>
Full article ">Figure 4
<p>Replication kinetics of H5N1<sub>EGY</sub> reassortants in mammalian cell culture models. Calu-3 and A549 cells were infected (in triplicates) with the H5N1<sub>EGY</sub> reassortants or wild-type H5N1<sub>EGY</sub> and control H5N1<sub>6H7N9Anhui</sub> at multiplicities of infection (MOIs) of 0.001 and incubated at 33 °C or 39 °C. At 6, 12, 24, 36 h p.i., the cell culture supernatants were collected and the virus titre was determined. Statistical analysis was performed using two-way ANOVA, followed by Bonferroni post hoc test. The significant differences are indicated (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001 and non-significant = ns).</p>
Full article ">Figure 5
<p>Pathogenicity of H5N1<sub>EGY</sub> and reassortants H5N1<sub>PB2-H9N2EGY</sub> and H5N1<sub>PA-H9N2EGY</sub> in female <span class="html-italic">BALB</span>/<span class="html-italic">c</span> mice. Mice were infected with 10<sup>5</sup> PFU of each virus in 100 μL phosphate-buffered saline (PBS). The morbidity rate and the mortality rate as demonstrated by weight loss of body (<b>a</b>) and the survival rate (<b>b</b>), respectively, were monitored for 14 dpi. Mice judged moribund (body weight loss &gt;25%) were euthanized.</p>
Full article ">Figure 6
<p>Prevalence of lysine and argenine at amino acid (aa) residue 367 among Egyptian human and avian H5N1 isolates (2006 to 2017). The graphic was created via Web-based WebLogo application (<a href="http://weblogo.threeplusone.com/create.cgi" target="_blank">http://weblogo.threeplusone.com/create.cgi</a>) [<a href="#B29-viruses-12-01046" class="html-bibr">29</a>]. The aa color is given according to their chemical properties. Polar aa “T and S”: green; neutral aa “Q”: purple; basic aa “K and R”: blue; hydrophobic aa “M, L, W, A and L”: black.</p>
Full article ">Figure 7
<p>Impact of PA-367K on the replication efficiency of H5N1<sub>EGY</sub> in mammalian cell culture models. (<b>a</b>) mammalian differentiated primary bronchial epithelial cells (NHBE) cells were infected (in triplicates) with wild-type H5N1<sub>EGY</sub>, reassortant H5N1<sub>PA-H9N2EGY</sub>, as well as mutant H5N1<sub>PA_R367K</sub> and H5N1<sub>PA-H9N2EGY_K367R</sub> at MOI of 1, cultured at 37 °C for 6–36 h p.i. (<b>b</b>) A549 and (<b>c</b>) Calu-3 were infected with wild-type H5N1<sub>EGY</sub> and mutant H5N1<sub>PA_R367K</sub> (MOI = 0.01) and cultured at 33 °C and 39 °C for 6–36 h p.i. Subsequently the virus titers were determined. Error bars reflect standard deviation (SD) of three independent experiments. Statistical analysis was performed using repeated measures ANOVA, followed by Bonferroni post hoc test. The significant differences are indicated (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001 and non-significant = ns).</p>
Full article ">Figure 8
<p>PA-367K does not significantly alter the in vitro polymerase activity of H5N1<sub>EGY</sub> in human 293T cells. The 293T cells were transfected with plasmids expressing the three subunits (PB2, PB1, PA) of the viral RNA-dependent RNA polymerase (RdRp) and the viral nucleoprotein (NP) of H5N1<sub>EGY</sub> or H9N2<sub>EGY</sub> (controls) or combinations of H5N1<sub>EGY</sub> PB2, PB1 and NP with mutated PA of H5N1<sub>EGY</sub> (PA_R367K) or of H9N2<sub>EGY</sub> (PA-H9N2EGY_K367R), as well as wild-type PA of H9N2<sub>EGY</sub> (PA-H9N2EGY). Along with the three RdRp subunits and NP expressing plasmids, a Renilla luciferase expression plasmid (transfection control) and a vector expressing a vRNA-like Pol-1 transcript encoding the firefly luciferase was co-transfected. At 48 h p.t., the control and transfected cells were analyzed for Renilla/luciferase expression levels. The significance was tested using one-way analysis of variance ANOVA, followed by Dunnett’s multiple comparison post hoc test and the significant differences are indicated (** = <span class="html-italic">p</span> &lt; 0.01 and non-significant = ns).</p>
Full article ">Figure 9
<p>Pathogenicity of wild-type H5N1<sub>EGY,</sub> H9N2<sub>EGY</sub>, reassortants H5N1<sub>PB2-H9N2EGY</sub> and H5N1<sub>PA-H9N2EGY</sub>, mutants H5N1<sub>PA_R367K</sub> and H5N1<sub>PA-H9N2EGY_K367R</sub> in female BALB/c mice. Mice were infected with 10<sup>3</sup> PFU of each virus in 30 μL PBS. (<b>a</b>) The body-weight reduction rate and the mortality rate as demonstrated by weight loss (<b>a</b>) and the survival rate (<b>b</b>), respectively, were monitored for 14 dpi. Mice judged moribund (body weight loss &gt; 25%) were euthanized.</p>
Full article ">
9 pages, 2016 KiB  
Article
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
by Kirsten Alexandra Eberhardt, Charlotte Meyer-Schwickerath, Eva Heger, Elena Knops, Clara Lehmann, Jan Rybniker, Philipp Schommers, Dennis A. Eichenauer, Florian Kurth, Michael Ramharter, Rolf Kaiser, Udo Holtick, Florian Klein, Norma Jung and Veronica Di Cristanziano
Viruses 2020, 12(9), 1045; https://doi.org/10.3390/v12091045 - 18 Sep 2020
Cited by 48 | Viewed by 5091
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health emergency. To improve the understanding of the systemic component of SARS-CoV-2, we investigated if viral load dynamics in plasma and respiratory samples are associated with antibody response and severity of coronavirus disease [...] Read more.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health emergency. To improve the understanding of the systemic component of SARS-CoV-2, we investigated if viral load dynamics in plasma and respiratory samples are associated with antibody response and severity of coronavirus disease 2019 (COVID-19). SARS-CoV-2 RNA was found in plasma samples from 14 (44%) out of 32 patients. RNAemia was detected in 5 out of 6 fatal cases. Peak IgG values were significantly lower in mild/moderate than in severe (0.6 (interquartile range, IQR, 0.4–3.2) vs. 11.8 (IQR, 9.9–13.0), adjusted p = 0.003) or critical cases (11.29 (IQR, 8.3–12.0), adjusted p = 0.042). IgG titers were significantly associated with virus Ct (Cycle threshold) value in plasma and respiratory specimens ((ß = 0.4, 95% CI (confidence interval, 0.2; 0.5), p < 0.001 and ß = 0.5, 95% CI (0.2; 0.6), p = 0.002). A classification as severe or a critical case was additionally inversely associated with Ct values in plasma in comparison to mild/moderate cases (ß = −3.3, 95% CI (−5.8; 0.8), p = 0.024 and ß = −4.4, 95% CI (−7.2; 1.6), p = 0.007, respectively). Based on the present data, our hypothesis is that the early stage of SARS-CoV-2 infection is characterized by a primary RNAemia, as a potential manifestation of a systemic infection. Additionally, the viral load in plasma seems to be associated with a worse disease outcome. Full article
(This article belongs to the Collection Coronaviruses)
Show Figures

Figure 1

Figure 1
<p>Individual longitudinal development of virologic and serological results of 32 patients with coronavirus disease 2019 (COVID-19) infection during hospital admission. Negative PCR results are displayed above the detection Ct (Cycle threshold) of 40. Dashed horizontal lines display the detection threshold of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA Ct values and the antibody cut-off of seroconversion for the assay used. RT-PCR, real-time PCR.</p>
Full article ">Figure 2
<p>Molecular and serological parameters according to disease severity in COVID-19 patients. (<b>A</b>) Lowest detected SARS-CoV-2 RNA RT-PCR Ct value in respiratory samples per patient; (<b>B</b>) nadir SARS-CoV-2 RNA RT-PCR plasma Ct value per patient; (<b>C</b>) peak IgG value per patient; * <span class="html-italic">p</span> &lt; 0.05; error bars, 95% confidence interval.</p>
Full article ">Figure 3
<p>SARS-CoV-2 Ct values in relation to IgG ratios according to COVID-19 severity. (<b>A</b>) Relation of SARS-CoV-2 respiratory Ct values with IgG values at the same day ± 2 days; (<b>B</b>) relation of SARS-CoV-2 plasma Ct values with IgG values at the same day ± 2 days in patients with mild or moderate, severe, or critical COVID-19 disease severity. Negative PCR results are displayed above the detection Ct of 40. Dashed horizontal lines display the detection threshold of SARS-CoV-2 RNA Ct values and the antibody cut-off of seroconversion for the assay used.</p>
Full article ">
21 pages, 3726 KiB  
Article
Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line
by Hossein M. Elbadawy, Mohi I. Mohammed Abdul, Naif Aljuhani, Adriana Vitiello, Francesco Ciccarese, Mohamed A. Shaker, Heba M. Eltahir, Giorgio Palù, Veronica Di Antonio, Hanieh Ghassabian, Claudia Del Vecchio, Cristiano Salata, Elisa Franchin, Eleonora Ponterio, Saleh Bahashwan, Khaled Thabet, Mekky M. Abouzied, Ahmed M. Shehata, Cristina Parolin, Arianna Calistri and Gualtiero Alvisiadd Show full author list remove Hide full author list
Viruses 2020, 12(9), 1044; https://doi.org/10.3390/v12091044 - 18 Sep 2020
Cited by 6 | Viewed by 4112
Abstract
Despite the introduction of directly acting antivirals (DAAs), for the treatment of hepatitis C virus (HCV) infection, their cost, patient compliance, and viral resistance are still important issues to be considered. Here, we describe the generation of a novel JFH1-based HCV subgenomic replicon [...] Read more.
Despite the introduction of directly acting antivirals (DAAs), for the treatment of hepatitis C virus (HCV) infection, their cost, patient compliance, and viral resistance are still important issues to be considered. Here, we describe the generation of a novel JFH1-based HCV subgenomic replicon double reporter cell line suitable for testing different antiviral drugs and therapeutic interventions. This cells line allowed a rapid and accurate quantification of cell growth/viability and HCV RNA replication, thus discriminating specific from unspecific antiviral effects caused by DAAs or cytotoxic compounds, respectively. By correlating cell number and virus replication, we could confirm the inhibitory effect on the latter of cell over confluency and characterize an array of lentiviral vectors expressing single, double, or triple cassettes containing different combinations of short hairpin (sh)RNAs, targeting both highly conserved viral genome sequences and cellular factors crucial for HCV replication. While all vectors were effective in reducing HCV replication, the ones targeting viral sequences displayed a stronger antiviral effect, without significant cytopathic effects. Such combinatorial platforms as well as the developed double reporter cell line might find application both in setting-up anti-HCV gene therapy approaches and in studies aimed at further dissecting the viral biology/pathogenesis of infection. Full article
(This article belongs to the Special Issue RNA Interference (RNAi) for Antiviral Therapy)
Show Figures

Figure 1

Figure 1
<p>Generation and characterization of lentiviral particles encoding shRNAs targeting hepatitis C virus (HCV) replication. (<b>A</b>) Schematic representation of the different lentiviral vectors generated. The shRNA cassettes were inserted between the XbaI and XhoI sites of lentiviral vector pLL3.7 under the control of pol-III promoters. The name of the different vectors is reported on the right panel. (<b>B</b>) Effect of lentiviral transduction on cell growth and viability; 9 × 10<sup>4</sup> Huh7.5 cells/cm<sup>2</sup> were seeded in 96-well plates; 24 h later cells were transduced with the lentiviral particles described in panel (<b>A</b>), at the MOI of 0.062 TU/cell. At the indicated time points p.t., cells were processed for MTT assays to calculate cell metabolic activity. Data are expressed as a percentage of those obtained for cells transduced with the control lentivirus pLL3.7/U6-shScrambled. Data are the mean + standard error of the mean of three independent experiments performed in triplicate. (<b>C</b>) 2.1 × 10<sup>4</sup> Huh7.5 cells/cm<sup>2</sup> were seeded in 12-well plates and, 24 h later, transduced at MOI of 1.25 TU/cell for each lentiviral vector targeting the indicated sequence. 72 h p.t., cells were lysed and processed for shRNA quantification as described in the Materials and Methods section. Data shown are the expression of the specific siRNA from the indicated lentiviral vectors relative to that achieved after transduction with the single shRNA lentiviral vector. Green bars: shRNA located in the first position of the promoter array. Yellow bars: shRNA located in the second position of the promoter array. Blue bars: shRNA located in the third position of the promoter array. Red bars: lhRNAs expressed under transcriptional control of the U6 promoter. Data are the mean ± standard error of the mean relative to three independent experiments.</p>
Full article ">Figure 2
<p>Generation of an HCV subgenomic double reporter replicon cell line allows accurate quantification of cell number. (<b>A</b>) Lunet cells were transduced with pWPI-HA-RLuc, mediating expression of the HA-RLuc reporter under control of the EF1α promoter. Transduced cells were selected using Puromycin to generate Lunet-RLuc cells, allowing to easily monitor cell number and viability by firefly luciferase assays. Subsequently cells were electroporated with in vitro transcribed RNA from plasmid pFKI389Luc-ubi-neo/NS3-3′_dg_JFH. Cells stably replicating HCV subgenomic RNA were selected using G418 (750 µg/mL) to generate FLuc-JFH1/RLuc cells, allowing to simultaneously monitor cell number and viral replication by dual luciferase assays. (<b>B</b>). Different amounts of FLuc-JFH1/RLuc cells were seeded either in 96- (for MTT assays) or 24- (for RLuc assays) well plates and incubated for the indicated time points before being processed as described in the Materials and Methods section. (<b>C</b>) Measurements relative to 2 × 10<sup>4</sup> cells seeded/cm<sup>2</sup>, cultured for the indicated time, are expressed as the percentage of the signals obtained 48 h post-seeding. The R<sup>2</sup> relative to the linear regression between Abs at 620 nm (blue circles) and RLuc values (red circles) is shown. Data are mean + standard error of the mean relative to three independent experiments. (<b>D</b>) Data relative to the indicated number of cells seeded/cm<sup>2</sup> and cultured for 96 h, are expressed as the percentage of the signals obtained for 5 × 10<sup>3</sup> cells seeded/cm<sup>2</sup>. The R<sup>2</sup> relative to the linear regression between Abs 620 nm (blue circles) and RLuc values (red circles) is shown. Data are mean ± standard error of the mean relative to three independent experiments.</p>
Full article ">Figure 3
<p>Quantification of cell number and viral replication of a HCV double reporter subgenomic replicon cell line. (<b>A</b>). Different amounts of FLuc-JFH1/RLuc cells were seeded in 24-well plates and incubated for the indicated time points before being lysed and processed for luminometric detection of RLuc and FLuc signals, allowing to calculate the relative HCV replication as reported by the FLuc/RLuc ratio. (<b>B</b>) FLuc (blue circles) and RLuc (red circles) were expressed as the percentage of the signals obtained for the indicated different times post-seeding and number of cell seeded, relative to 48 h post-seeding, whereas the FLuc/RLuc ratios relative to each condition are shown as white bars. (<b>C</b>). FLuc (blue circles) and RLuc (red circles) were expressed as the percentage of the signals obtained at the indicated time point post-seeding and number of cell seeded, relative to 5 × 10<sup>3</sup> cells cm<sup>2</sup>/seeded, whereas the FLuc/RLuc ratios relative to each condition are shown as white bars. Data are mean ± standard error of the mean relative to data repeated in three independent experiments. * = cells overconfluent.</p>
Full article ">Figure 4
<p>Effect of different compounds on HCV replication and cell viability. (<b>A</b>) FLuc-JFH1/RLuc cells were seeded in 24-well plates (2.5 × 10<sup>4</sup> cells/cm<sup>2</sup>); 24 h later, cells were treated with increasing concentrations of the indicated compounds; 72 h post-treatment, cells were lysed and processed for luciferase assays for the quantification of viral RNA replication (FLuc) and cell number/viability (RLuc), as described in the Materials and Methods section. (<b>B</b>) Curves such as those shown in (<b>C</b>) were analysed as described in the Materials and Methods section in order to calculate the effective dose 50 (ED<sub>50</sub>; FLuc), cell culture 50 (CC<sub>50</sub>; RLuc) and normalized ED<sub>50</sub> (FLuc/RLuc), relative to the indicated compounds. Data shown are the mean + standard deviation of the mean relative to the indicated number of independent experiments (<span class="html-italic">n</span>). (<b>C</b>) The FLuc (left panels, blue lines) and RLuc (left panels, red lines) activities, as well as the FLuc/RLuc ratio (right panels) relative to each condition were expressed as a percentage of the vehicle treated cells and representative curves relative to the indicated treatments are shown.</p>
Full article ">Figure 5
<p>MOI-dependent inhibition of HCV replication as mediated by single miRNA-expressing pLL3.7 vectors. (<b>A</b>) 2 × 10<sup>4</sup> cells/cm<sup>2</sup> and 1 × 10<sup>4</sup> cells/cm<sup>2</sup> of FLuc-JFH1/RLuc cells were seeded in 24-well plates, cultured at 37 °C in a humidified incubator for further 24 h, and transduced at a MOI of 2 or of 10 TU/cell with pLL3.7-derived lentiviral particles encoding single shRNAs targeting the indicated sequences for 72 and 144 h, respectively. At the indicated time points p.t., cells were lysed and processed for fluorimetric detection of transduction efficiency (GFP) and luminometric detection of cell number (RLuc) and HCV replication (FLuc), allowing to calculate the relative HCV replication indicated by the FLuc/RLuc ratio. The FLuc/RLuc ratio relative to cells transduced with the indicated lentiviruses is shown at 72 (<b>B</b>) and 144 (<b>C</b>) h p.t., and for MOI of 2 (<b>D</b>) and MOI of 10 (<b>E</b>), expressed as a percentage of the mean values obtained for cells transduced with pLL3.7 encoding for a non-targeting shRNA (Scrambled). The latter, relative to cells transduced with a MOI of 10 is also compared to the GFP/RLuc ratio expressed as percentage of mean values obtained for cells transduced with pLL3.7 encoding for a non-targeting shRNA (Scrambled) at 72 (<b>F</b>) and 144 (<b>G</b>) h p.t. Data are the mean + standard error of the mean relative to three independent experiments. * = <span class="html-italic">p</span> ≤ 0.05; ** = <span class="html-italic">p</span> ≤ 0.005; *** = <span class="html-italic">p</span> ≤ 0.0005.</p>
Full article ">Figure 6
<p>Inhibition of HCV replication as mediated by the combination of miRNA-expressing pLL3.7 vectors. (<b>A</b>) 2 × 10<sup>4</sup> cells/cm<sup>2</sup> and 1 × 10<sup>4</sup> cells/cm<sup>2</sup> of FLuc-JFH1/RLuc cells were seeded in 24-well plates, and after 24 h were transduced with different lentiviral vectors encoding for a combination of shRNAs/lhRNAs targeting the sequences described in the Material and Methods for 72 and 144 h p.t., respectively. At the indicated time points p.t., cells were lysed and processed for fluorimetric detection of transduction efficiency (GFP) and luminometric detection of cell number (RLuc) and HCV replication (FLuc). The FLuc/RLuc (blue columns) and GFP/RLuc (red bars) ratios relative to cells transduced with the indicated pLL3.7 shRNA/lhRNA lentiviruses at 72 (<b>B</b>) and 144 (<b>C</b>) h p.t., are expressed as a percentage of the mean values obtained for cells transduced with pLL3.7 encoding for a non-targeting shRNA (Scrambled). Data are the mean + standard error of the mean relative to three independent experiments. Adjusted <span class="html-italic">p</span> values from the Turkey multiple-comparison post-test are reported for the FLuc/RLuc ratios relative to cells transduced with each lentiviral particle at 72 (<b>D</b>) and 144 (<b>E</b>) h p.t. Green: <span class="html-italic">p</span> value &lt; 0.05; pink: 0.05 &lt; <span class="html-italic">p</span> value &lt; 0.5; red: <span class="html-italic">p</span> value &gt; 0.5; black: no <span class="html-italic">p</span> value calculated. Lentiviral vectors were as follows: #1, pLL3.7/U6-shCypA; #2, pLL3.7/U6-shHCV321; #3, pLL3.7/U6-shPI4KIIIα; #4, pLL3.7/U6-shScrambled;#5, pLL3.7/U6-shHCV321-H1-shCyp-7SK-shHCV353;#6, pLL3.7/U6-shPI4KIIIα-7SK-shHCV321-H1-shCypA; #7, pLL3.7/U6-shHCV321-7SK-shPI4KIIIα-H1-shHCV353; #8, pLL3.7/U6-shHCV321-7SK-shPI4KIIIα-H1-shCypA; #9, pLL3.7/U6-lhHCV321-CypA; #10, pLL3.7/U6-lhHCV-PI4KIIIα.</p>
Full article ">Figure 7
<p>Schematic representation of the study experimental set up. (<b>A</b>) We established a double reporter HCV replicon cell line allowing simultaneous luminometric quantification of HCV genotype 2a JFH1 replication (FLuc) and cell proliferation/viability (RLuc). Such cell line can be used for several applications including: testing the effect of cell culture conditions on HCV replication (<b>B</b>), antiviral compounds identification/screening (<b>C</b>), or gene silencing experiments aimed at identifying new host factors, as well as optimization of conditions for therapeutic gene silencing (<b>D</b>).</p>
Full article ">
18 pages, 5160 KiB  
Article
Merkel Cell Polyomavirus Large T Antigen Unique Domain Regulates Its Own Protein Stability and Cell Growth
by Nnenna Nwogu, Luz E. Ortiz and Hyun Jin Kwun
Viruses 2020, 12(9), 1043; https://doi.org/10.3390/v12091043 - 18 Sep 2020
Cited by 9 | Viewed by 4402
Abstract
Merkel cell polyomavirus (MCV) is the only known human oncogenic virus in the polyomaviridae family and the etiological agent of most Merkel cell carcinomas (MCC). MCC is an aggressive and highly metastatic skin cancer with a propensity for recurrence and poor prognosis. Large [...] Read more.
Merkel cell polyomavirus (MCV) is the only known human oncogenic virus in the polyomaviridae family and the etiological agent of most Merkel cell carcinomas (MCC). MCC is an aggressive and highly metastatic skin cancer with a propensity for recurrence and poor prognosis. Large tumor antigen (LT), is an essential oncoprotein for MCV transcription, viral replication, and cancer cell proliferation. MCV LT is a short-lived protein that encodes a unique domain: MCV LT unique regions (MURs). These domains consist of phosphorylation sites that interact with multiple E3 ligases, thus limiting LT expression and consequently, viral replication. In this study, we show that MURs are necessary for regulating LT stability via multiple E3 ligase interactions, resulting in cell growth arrest. While expression of wild-type MCV LT induced a decrease in cellular proliferation, deletion of the MUR domains resulted in increased LT stability and cell proliferation. Conversely, addition of MURs to SV40 LT propagated E3 ligase interactions, which in turn, reduced SV40 LT stability and decreased cell growth activity. Our results demonstrate that compared to other human polyomaviruses (HPyVs), MCV LT has evolved to acquire the MUR domains that are essential for MCV LT autoregulation, potentially leading to viral latency and MCC. Full article
(This article belongs to the Special Issue Polyomaviruses)
Show Figures

Figure 1

Figure 1
<p>Merkel cell polyomavirus large tumor antigen (MCV LT) similarity and disorder plots. (<b>A</b>) LT amino acid similarity of 14 human polyomaviruses (HPyVs) and disordered region of MCV LT protein. Sliding window plot (6 aa window size) analysis. LT amino acid similarity was compared using PLOTCON (EMBOSS). For disordered region prediction, IUPred2 and ANCHOR2 were utilized to identify disordered protein regions and disordered binding regions in MCV LT, respectively. MCV LT contains a unique disordered region (MUR) divided in two fragments by the conserved LXCXE motif [<a href="#B23-viruses-12-01043" class="html-bibr">23</a>,<a href="#B24-viruses-12-01043" class="html-bibr">24</a>]. (<b>B</b>) Diagram of MCV LT and SV40 LT domain structures. Compared with SV40 LT, MCV LT has an extended structure, MUR, that serves as an interacting domain with multiple cellular factors. The MUR domain also consists of phosphorylated serines for SCF E3 ligase recognition (phospho-degron motifs) [<a href="#B15-viruses-12-01043" class="html-bibr">15</a>].</p>
Full article ">Figure 2
<p>MCV LT unique region (MUR) regulates LT stability. (<b>A</b>) Diagram of MCV LT coding regions and sites of deletion mutations. MCV LT MUR domains: MUR1 (102–207 aa) and MUR2 (220–258 aa) were simultaneously deleted to evaluate LT stability. (<b>B</b>) LT MUR destabilizes LT. LT protein turnover was measured by a cycloheximide (CHX) chase assay using quantitative immunoblot analysis. Cells transfected with LT<sub>WT</sub> or LT<sub>dMUR</sub> constructs (0.3 µg and 0.9 µg respectively) were treated with CHX (0.1 mg/mL) 24 h after transfection and harvested at each time point indicated. (<b>C</b>) Protein expression was quantified using a LI-COR IR imaging system. Deletion of the MUR extended the half-life of LT from ~3–4 h up to &gt;8 h. Error bars represent SEM and were calculated using GraphPad Prism software. Data were analyzed using three biological replicates per experiment, <span class="html-italic">n</span> = 3. (<b>D</b>) Diagram of SV40 LT coding regions and sites of insertion mutations. SV40 LT amino acids (99–123) were deleted, and the MCV LT complete MUR domain (102–258 aa) was inserted. (<b>E</b>) MCV LT MUR destabilizes SV40 LT. SV40 LT protein turnover was assessed by a CHX chase assay using quantitative immunoblot analysis. 293 cells transfected with either wild-type SV40 LT (SV40 LT<sub>WT</sub>) (0.3 µg) or SV40 LT<sub>+MUR</sub> (0.6 µg) were treated with CHX (0.1 mg/mL) 24 h after transfection and harvested at each time point indicated. (<b>F</b>) Protein expression was quantified using the laser-scanning Odyssey CLX (LI-COR) infrared (IR) imaging system. MCV MUR insertion into SV40 LT reduced SV40 LT turnover to ~6 h. Error bars represent standard errors of the mean (SEM) and were calculated using GraphPad Prism software. Data were analyzed using three biological replicates per experiment, <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 3
<p>MCV LT maintains origin binding and replication capacity independent of the MUR domain. (<b>A</b>) Schematic of MCV LT coding regions and sites of deletion mutations. MCV LT MUR1 (102–207 aa) (LT<sub>dM1</sub>), MUR2 (220-258 aa) (LT<sub>dM2</sub>) or MUR1+MUR2 (LT<sub>dMUR</sub>) (102-258aa) were deleted to evaluate LT mediated viral replication. (<b>B</b>) Diagram of MCV transcription reporter. The MCV promoter region (nt 4928–195; GenBank accession no. EU375804) was cloned into a bidirectional dual Firefly (early) and Renilla (late) luciferase reporter [<a href="#B15-viruses-12-01043" class="html-bibr">15</a>]. (<b>C</b>) Early gene transcription activity was measured by luciferase activity using co-transfection of the reporter (0.5 µg) with either wild-type LT or MUR deletion mutants (0.5 µg) into 293 cells. Relative luciferase activity was normalized to empty vector control (mean ± SEM, <span class="html-italic">n</span> = 3). Deletion of either MUR1 or MUR2 impaired repression of MCV early gene transcription while deletion of both MUR1 and MUR2 (dMUR) successfully downregulated MCV early gene transcription compared to wild-type LT. There was no significant increased late gene transcription by either LT<sub>wt</sub> or mutant LTs because no robust amplification of origin replication occurred as shown in <a href="#viruses-12-01043-f003" class="html-fig">Figure 3</a>D. Similar results are observed using the replication-deficient reporter [<a href="#B15-viruses-12-01043" class="html-bibr">15</a>]. (<b>D</b>) MCV origin replication assay. Either deletion of MUR1 or MUR2 impaired MCV origin replication. Deletion of both MUR1 and MUR2 (LT<sub>dMUR</sub>) retained its ability to replicate MCV origin as compared to wild-type LT. Error bars represent SEM and were calculated using GraphPad Prism software. Data were analyzed using three biological replicates per experiment, <span class="html-italic">n</span> = 3. Differences between means (*, <span class="html-italic">p</span> value ≤ 0.05) were analyzed using a <span class="html-italic">t</span>-test with GraphPad Prism software.</p>
Full article ">Figure 4
<p>MCV LT MUR regulates cell growth inhibition activity of LT. (<b>A</b>) Diagram of MCV LT and SV40 LT lentiviral constructs used for cell proliferation analysis. Enhanced GFP (eGFP) was tagged to the N-terminus. P2A self-cleaving peptide was fused between eGFP and LT sequences to allow non-tagged LT expression. (<b>B</b>) Immunoblot analysis of eGFP expression in BJ-hTERT fibroblasts. eGFP can effectively be used as a marker of LT expression. (<b>C</b>) Validation of the P2A lentivirus system by immunofluorescence staining. Cells were fixed, and GFP fluorescence was analyzed by direct visualization, whereas LT antigen expression was identified by indirect immunofluorescence using specific antibodies. Nuclear counterstain (DAPI-Blue), GFP for T antigen expression (Green), and various T antigen antibodies (Pab416, 2T2, CM2B4) (Red). Scale bar = 10 µm. (<b>D</b>) MCV LT MUR regulates serum-independent human BJ-hTERT cell proliferation. LT proteins were transduced by lentiviral vector into immortalized BJ-hTERT cells, and cell proliferation was determined in 0.1% FBS using a CCK-8 colorimetric cell proliferation assay. Wild-type LT mediated cell growth inhibition, as previously reported [<a href="#B7-viruses-12-01043" class="html-bibr">7</a>,<a href="#B8-viruses-12-01043" class="html-bibr">8</a>]. In the absence of MUR, LT accelerated BJ-hTERT cell growth (normalized by mean OD values on day 1 for two independent experiments performed in triplicate). In contrast, wild-type SV40 LT promoted cell proliferation while the insertion of MCV MUR decreased cell proliferation potential in the absence of serum.</p>
Full article ">Figure 5
<p>MCV LT MUR is LT-FBW7 and Skp2 interaction domain. (<b>A</b>) MCV LT MUR interacts with SCF E3 ligase complexes. HA-tagged F-box proteins (FBW7 and Skp2) (6 µg) were co-transfected with LTs (6 µg) into 293 cells, and proximity ligation assay (PLA)-flow cytometric analysis was performed with anti-HA and either 2T2 (MCV LT) or pAb416 (SV40 LT) antibodies. c-Myc/FBW7 interaction was included as a positive control for PLA-flow cytometry. Wild-type LT mediated E3 ligase interaction through the known serine phosphorylation sites within the MUR domain, as previously reported [<a href="#B15-viruses-12-01043" class="html-bibr">15</a>]. Insertion of the MCV LT MUR into SV40 LT (SV40 LT<sub>+MUR</sub>) increased Skp-Cullin-F-box (SCF) protein interactions. (<b>B</b>) Calculated fold difference of mean fluorescence intensity of PLA analyzed by Flow Jo software. (<b>C</b>) Protein expression was evaluated by immunoblot analysis.</p>
Full article ">Figure 6
<p>Serines 142 and 147 are the LT phosphorylation sites for β-TrCP recruitment. (<b>A</b>) β-TrCP binds to the DpSGXX(X)pS dual-site phosphorylation motif in its substrates [<a href="#B38-viruses-12-01043" class="html-bibr">38</a>]. (<b>B</b>) MCV LT MUR interacts with β-TrCP. β-TrCP (6 µg) was co-transfected with LTs (6 µg) into 293 cells, and PLA-flow cytometric analysis was performed with anti-HA and either 2T2 (MCV LT) or pAb416 (SV40 LT) antibodies. c-Myc/FBW7 interaction was included as a positive control for PLA-flow cytometry. (<b>C</b>) Calculated fold difference of mean fluorescence intensity of PLA analyzed by Flow Jo software. (<b>D</b>) Protein expression was evaluated by immunoblot analysis. (<b>E</b>) LT alanine (Ala, A) substitution mutants at S142 and S147 potential β-TrCP binding residues were tested for stability by a CHX chase assay using quantitative immunoblot analysis. Cell transfected with LTs (0.5 µg) were treated with CHX (0.1 mg/mL) 24 h after transfection and harvested at each time point indicated. (<b>F</b>) Protein expression was quantified in triplicate using an LI-COR IR imaging system. Error bars represent SEM; n = 3. Both S147 and S142 to Ala mutations along with the double mutant increased LT stability. The double mutant is the most stable of all three while S147A mutant is more stable than S142A.</p>
Full article ">
14 pages, 3035 KiB  
Article
Divergent Influenza-Like Viruses of Amphibians and Fish Support an Ancient Evolutionary Association
by Rhys Parry, Michelle Wille, Olivia M. H. Turnbull, Jemma L. Geoghegan and Edward C. Holmes
Viruses 2020, 12(9), 1042; https://doi.org/10.3390/v12091042 - 18 Sep 2020
Cited by 24 | Viewed by 8771
Abstract
Influenza viruses (family Orthomyxoviridae) infect a variety of vertebrates, including birds, humans, and other mammals. Recent metatranscriptomic studies have uncovered divergent influenza viruses in amphibians, fish and jawless vertebrates, suggesting that these viruses may be widely distributed. We sought to identify additional [...] Read more.
Influenza viruses (family Orthomyxoviridae) infect a variety of vertebrates, including birds, humans, and other mammals. Recent metatranscriptomic studies have uncovered divergent influenza viruses in amphibians, fish and jawless vertebrates, suggesting that these viruses may be widely distributed. We sought to identify additional vertebrate influenza-like viruses through the analysis of publicly available RNA sequencing data. Accordingly, by data mining, we identified the complete coding segments of five divergent vertebrate influenza-like viruses. Three fell as sister lineages to influenza B virus: salamander influenza-like virus in Mexican walking fish (Ambystoma mexicanum) and plateau tiger salamander (Ambystoma velasci), Siamese algae-eater influenza-like virus in Siamese algae-eater fish (Gyrinocheilus aymonieri) and chum salmon influenza-like virus in chum salmon (Oncorhynchus keta). Similarly, we identified two influenza-like viruses of amphibians that fell as sister lineages to influenza D virus: cane toad influenza-like virus and the ornate chorus frog influenza-like virus, in the cane toad (Rhinella marina) and ornate chorus frog (Microhyla fissipes), respectively. Despite their divergent phylogenetic positions, these viruses retained segment conservation and splicing consistent with transcriptional regulation in influenza B and influenza D viruses, and were detected in respiratory tissues. These data suggest that influenza viruses have been associated with vertebrates for their entire evolutionary history. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Genome architecture of the novel influenza-like viruses identified here. Genome architecture of influenza A virus (IAV)/influenza B virus (IBV) and influenza C virus (ICV)/influenza D virus (IDV) is shown on the left. For each novel virus, we provide the segment name and size. PB1, RNA-dependent RNA polymerase basic subunit 1; PB2, RNA-dependent RNA polymerase basic subunit 2; PA, RNA-dependent RNA polymerase acidic subunit; P3, Polymerase protein 3; NP, nucleoprotein; HA, hemagglutinin; NB, glycoprotein NB; HEF, hemagglutinin esterase; NA, neuraminidase; M, matrix; CM1, viral matrix protein; NS, non-structural protein; NEP nuclear export protein. Detailed annotations for each virus are presented in <a href="#app1-viruses-12-01042" class="html-app">Supplementary Tables S1–S6 and Figures S1–S5</a>.</p>
Full article ">Figure 2
<p>Phylogenetic relationships of vertebrate influenza-like viruses. Maximum likelihood tree of the PB1 segment, which encodes the RNA-dependent RNA polymerase, of various influenza-like viruses. Lineages corresponding to IAV, IBV, ICV, IDV are coloured blue, green, red and orange, respectively. Viruses identified in this study are denoted by a black circle and pictogram of the host species of the library. Wenling hagfish influenza virus is set as the outgroup as per Shi et al. [<a href="#B3-viruses-12-01042" class="html-bibr">3</a>]. The scale bar indicates the number of amino acid substitutions per site.</p>
Full article ">Figure 3
<p>Phylogenetic trees for segments in cases where complete coding genomes could be recovered. Maximum likelihood trees for each segment ordered by (segment) size. Lineages are coloured by influenza virus, in which IAV, IBV, ICV, IDV are coloured blue, green, red and orange, respectively. Viruses identified in this study are denoted by a black circle and pictogram of the host species of the library. The phylogenetic position of each virus is traced across the trees with grey dashed lines. ICV, IDV, cane toad and chorus frog influenza-like viruses do not have an NA segment. The scale bar for each tree indicates the number of amino acid substitutions per site. Where possible, the trees are rooted using the hagfish influenza virus (PB2, PB1, PA/P3, NP). The HA/HEF, M and NS trees were midpoint rooted.</p>
Full article ">Figure 4
<p>Heat map of the abundance of salamander influenza-like virus reads in the multi-tissue transcriptome library of developmental stages of plateau tiger salamander [<a href="#B44-viruses-12-01042" class="html-bibr">44</a>]. Read abundance for this virus was highest in the gills of late metamorphosis salamanders, and lungs of post metamorphosis salamander, strongly suggesting tropism for respiratory epithelium.</p>
Full article ">
24 pages, 3980 KiB  
Article
Identification of Inhibitors of ZIKV Replication
by Desarey Morales Vasquez, Jun-Gyu Park, Ginés Ávila-Pérez, Aitor Nogales, Juan Carlos de la Torre, Fernando Almazan and Luis Martinez-Sobrido
Viruses 2020, 12(9), 1041; https://doi.org/10.3390/v12091041 - 18 Sep 2020
Cited by 17 | Viewed by 4402
Abstract
Zika virus (ZIKV) was identified in 1947 in the Zika forest of Uganda and it has emerged recently as a global health threat, with recurring outbreaks and its associations with congenital microcephaly through maternal fetal transmission and Guillain-Barré syndrome. Currently, there are no [...] Read more.
Zika virus (ZIKV) was identified in 1947 in the Zika forest of Uganda and it has emerged recently as a global health threat, with recurring outbreaks and its associations with congenital microcephaly through maternal fetal transmission and Guillain-Barré syndrome. Currently, there are no United States (US) Food and Drug Administration (FDA)-approved vaccines or antivirals to treat ZIKV infections, which underscores an urgent medical need for the development of disease intervention strategies to treat ZIKV infection and associated disease. Drug repurposing offers various advantages over developing an entirely new drug by significantly reducing the timeline and resources required to advance a candidate antiviral into the clinic. Screening the ReFRAME library, we identified ten compounds with antiviral activity against the prototypic mammarenavirus lymphocytic choriomeningitis virus (LCMV). Moreover, we showed the ability of these ten compounds to inhibit influenza A and B virus infections, supporting their broad-spectrum antiviral activity. In this study, we further evaluated the broad-spectrum antiviral activity of the ten identified compounds by testing their activity against ZIKV. Among the ten compounds, Azaribine (SI-MTT = 146.29), AVN-944 (SI-MTT = 278.16), and Brequinar (SI-MTT = 157.42) showed potent anti-ZIKV activity in post-treatment therapeutic conditions. We also observed potent anti-ZIKV activity for Mycophenolate mofetil (SI-MTT = 20.51), Mycophenolic acid (SI-MTT = 36.33), and AVN-944 (SI-MTT = 24.51) in pre-treatment prophylactic conditions and potent co-treatment inhibitory activity for Obatoclax (SI-MTT = 60.58), Azaribine (SI-MTT = 91.51), and Mycophenolate mofetil (SI-MTT = 73.26) in co-treatment conditions. Importantly, the inhibitory effect of these compounds was strain independent, as they similarly inhibited ZIKV strains from both African and Asian/American lineages. Our results support the broad-spectrum antiviral activity of these ten compounds and suggest their use for the development of antiviral treatment options of ZIKV infection. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of the compounds: Groups of compounds include (<b>A</b>) inhibitors of adenosine triphosphate (ATP) synthesis (Antimycin A), (<b>B</b>) apoptosis inducers (OSU-03012 and Obatoclax), (<b>C</b>) inhibitors of orotidine monophosphate decarboxylase (OMPD), which catalyzes key steps in pyrimidine synthesis (Azaribine, Azauridine, and Pyrazofurin), (<b>D</b>) inhibitors of inosine monophosphate dehydrogenase (IMPDH) that inhibit replication of RNA and DNA via GTP reduction (Mycophenolate mofetil, Mycophenolic acid, and AVN-944), (<b>E</b>) inhibitors of dihydroorotate dehydrogenase (DHODH) that is a key enzyme of the pyrimidine biosynthesis pathway (Brequinar). (<b>F</b>) The JAK2 and STAT5 activator Aurintricarboxylic acid (ATA) was used as a positive control since it has been previously shown to have antiviral activity against ZIKV.</p>
Full article ">Figure 2
<p>Cytotoxicity of the ten tested compounds: Vero cells (96-well plate format, 5 × 10<sup>4</sup> cells/well, quadruplicates) were incubated with DMEM 5% FBS containing the indicated doses of the inhibitors (3-fold serial dilutions, starting concentration of 1350 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA). Cell viability assays (MTT and XTT) were performed at 36 h post-treatment and the CC<sub>50</sub> for each compound was calculated. Dotted line indicates the 50% toxicity of each of the compounds. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">Figure 3
<p>Inhibition of ZIKV Paraiba/2015 replication during post-treatment: Vero cells (96-well plate format, 5 × 10<sup>4</sup> cells/well, quadruplicates) were infected with 25 PFU/well of Zika virus Paraiba/2015. After 2 h of viral absorption, media containing virus was replaced by infection media (DMEM 2% FBS) containing the indicated doses of the inhibitors (3-folds dilutions, starting concentration 100 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA); and 1% Avicel. At 36 h post-treatment, the cells were fixed and immunoassayed using the anti-E 4G2 mAb. Plaques were counted with an automated ELISPOT reader. Dotted line indicates 50% inhibition. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">Figure 4
<p>Growth kinetics inhibition of ZIKV Paraiba/2015: Vero cells (24-well plate format, 2.5 × 10<sup>5</sup> cells/well, triplicates) were infected (MOI 0.1) with Paraiba/2015. After 2 h viral absorption, cells were treated with the indicated concentrations of compounds (0, 0.1, 1, and 10 EC<sub>50</sub>) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA); or 0.1% DMSO vehicle control (No drug) in infection media (DMEM 2% FBS). Tissue culture supernatants were collected at 24, 48, and 72 h post-treatment, and viral titers were calculated by immunostaining using the anti-E 4G2 mAb. Dotted line indicates the limit of detection (10 PFU). Data were expressed as mean and SD from three independent experiments conducted in triplicates. Statistical analysis was conducted by an unpaired Student’s t-test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, or no significance (n.s.).</p>
Full article ">Figure 5
<p>Inhibition of ZIKV Paraiba/2015 replication (pre-treatment): Vero cells in 96-well plate (5 × 10<sup>4</sup> cells/well; quadruplicates) were treated with infection media (DMEM 2% FBS) containing the indicated concentrations of the compounds (3-folds dilutions, starting concentration 100 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA). After 12 h of treatment, media was replaced, and cells were infected with Paraiba/2015 (25 PFU/well). After 2 h viral absorption, media was replaced by post-infection media. At 36 h post-infection, cells were fixed and immunoassayed using the anti-E 4G2 mAb. Plaques were counted with an automated ELISPOT reader. Dotted line indicates 50% inhibition. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">Figure 6
<p>Inhibition of ZIKV Paraiba/2015 with the compounds (co-treatment): ZIKV Paraiba/2015 (25 PFU/well) were pre-incubated in infection media (DMEM 2% FBS) containing the indicated concentrations of the compounds (3-folds dilutions, starting concentration 100 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA) for 1 h. Vero cells (96-well plates, 5 × 10<sup>4</sup> cells/well; quadruplicates) were then infected with the virus-compound mixtures and after 2 h viral absorption, media was replaced by post-infection media. At 36 h post-infection, the cells were fixed and immunoassayed with the anti-E 4G2 mAb. Plaques were counted with an automated ELISPOT reader. Dotted line indicates 50% inhibition. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">Figure 7
<p>Prevention of apoptosis-induced cell death: Vero cells (24-well plate format, 2.5 × 10<sup>5</sup> cells/well, triplicates) were infected (MOI 0.1) with Paraiba/2015. After 2 h viral absorption, infected cells were treated with the indicated concentrations of compounds (0, 0.1, 1, and 10 EC<sub>50</sub>) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA); and Caspase 3/7 levels were measured at 24, 48, and 72 h post-treatment. Data of each time point was compared to mock-infected control cells and expressed as mean of relative percentage and SD from three independent experiments conducted in triplicates. Statistical analysis was conducted by an unpaired Student’s <span class="html-italic">t</span>-test, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, or no significance (n.s.).</p>
Full article ">Figure 8
<p>Inhibition of African (MR-766) and Asian/American (PRVABC59) prototype ZIKV strains: Vero cells (96-well plates, 5 × 10<sup>4</sup> cells/well, quadruplicates) were infected with 25 PFU of MR-766, and 50 PFU of PRVABC59 ZIKV strains. After 2 h viral absorption, the indicated concentrations of compounds (3-folds dilutions, starting concentration 100 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA) were added to post-infection media. Infected cells were fixed for virus titration by immunostaining assay at 36 h (MR-766) or 48 h (PRVABC59) post-treatment. Dotted line indicates 50% inhibition. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">Figure 9
<p>Inhibition of ZIKV replication in A549 cells: Human A549 cells in 96-well plate (5 × 10<sup>4</sup> cells/well; quadruplicates) were infected (25 PFU/well) with Paraiba/2015. After 2 h viral absorption, post-infection media (DMEM 2% FBS) containing the indicated doses of the compounds (3-folds dilutions, starting concentration 100 µM) (<b>A</b>) Antimycin A, (<b>B</b>) OSU-03012 and Obatoclax, (<b>C</b>) Azaribine, Azauridine, and Pyrazofurin, (<b>D</b>) Mycophenolate mofetil, Mycophenolic acid, and AVN-944, (<b>E</b>) Brequinar, and (<b>F</b>) Aurintricarboxylic acid (ATA) were added. At 36 h post-treatment, infected cells were fixed and immunostained with the anti-E 4G2 mAb. Plaques were counted with an automated ELISPOT reader. Dotted line indicates 50% inhibition. Data were expressed as mean and SD from three independent experiments conducted in quadruplicates.</p>
Full article ">
22 pages, 1773 KiB  
Article
CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR
by Adhikarimayum Lakhikumar Sharma, Joseph Hokello, Shilpa Sonti, Sonia Zicari, Lin Sun, Aseel Alqatawni, Michael Bukrinsky, Gary Simon, Ashok Chauhan, Rene Daniel and Mudit Tyagi
Viruses 2020, 12(9), 1040; https://doi.org/10.3390/v12091040 - 18 Sep 2020
Cited by 21 | Viewed by 4098
Abstract
The C-promoter binding factor-1 (CBF-1) is a potent and specific inhibitor of the human immunodeficiency virus (HIV)-1 LTR promoter. Here, we demonstrate that the knockdown of endogenous CBF-1 in latently infected primary CD4+ T cells, using specific small hairpin RNAs (shRNA), resulted in [...] Read more.
The C-promoter binding factor-1 (CBF-1) is a potent and specific inhibitor of the human immunodeficiency virus (HIV)-1 LTR promoter. Here, we demonstrate that the knockdown of endogenous CBF-1 in latently infected primary CD4+ T cells, using specific small hairpin RNAs (shRNA), resulted in the reactivation of latent HIV proviruses. Chromatin immunoprecipitation (ChIP) assays using latently infected primary T cells and Jurkat T-cell lines demonstrated that CBF-1 induces the establishment and maintenance of HIV latency by recruiting polycomb group (PcG/PRC) corepressor complexes or polycomb repressive complexes 1 and 2 (PRC1 and PRC2). Knockdown of CBF-1 resulted in the dissociation of PRCs corepressor complexes enhancing the recruitment of RNA polymerase II (RNAP II) at HIV LTR. Knockdown of certain components of PRC1 and PRC2 also led to the reactivation of latent proviruses. Similarly, the treatment of latently infected primary CD4+ T cells with the PRC2/EZH2 inhibitor, 3-deazaneplanocin A (DZNep), led to their reactivation. Full article
(This article belongs to the Special Issue HIV-1 Transcription Regulation)
Show Figures

Figure 1

Figure 1
<p>Knockdown of C-promoter binding factor-1 (CBF-1) in primary CD4+ T cells reactivates latent human immunodeficiency virus (HIV) proviruses. (<b>a</b>) Structure of lentiviral vector (pHR’-PNL-Luc), which carries reporter luciferase gene under HIV LTR promoter. (<b>b</b>) Western blot demonstrating CBF-1 knockdown in cells expressing shRNAs against CBF-1, cells expressing scrambled shRNA and control unstimulated cells. (<b>c</b>) Densitometric analyses of immunoblot bands using ImageJ software, and represented graphically after normalization to actin. (<b>d</b>) Luciferase assay showing proviral reactivation in primary cells with pHR’-PNL-Luc that are superinfected with different amounts of lentiviral vectors expressing either shRNAs against CBF-1, scrambled shRNA and control unstimulated cells. Error bars represent the Mean ± SD of three independent and separate experiments. The <span class="html-italic">p</span> value of statistical significance was set as; <span class="html-italic">p</span> &lt; 0.05 (*), 0.01 (**) or 0.001 (***).</p>
Full article ">Figure 2
<p>Knockdown of polycomb group (PcG) complex led to proviral reactivation. Some of the core PcG complex components were knocked down individually by transfecting latently infected Jurkat-pHR’-PNL-Luc cells with four specific siRNAs. HIV-1 reactivation of latent provirus was quantified through luciferase assays performed after 52 h either post siRNA transfection or 48 h post DZNep treatment. (<b>a</b>) Western blot showing the efficiency of siRNA to knockdown indicated subunits of PRCs. The densitometry analyses were then represented graphically after normalization to actin. Quantitative luciferase assays marking proviral reactivation either after (<b>b</b>) knockdown of individual subunits belonging to PRCs or (<b>c</b>) upon DZNep treatment (from 2 µM to 32 µM) of cells. Graphs represent the average and standard deviation from three independent and replicate samples. Statistical analysis was done using Microsoft Excel and GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). The <span class="html-italic">p</span> value of statistical significance was set as: <span class="html-italic">p</span> &lt; 0.01 (**).</p>
Full article ">Figure 3
<p>CBF-1 restricts HIV transcription by inducing multiple types of repressive epigenetic modifications at HIV LTR. Chromatin immunoprecipitation (ChIP) analyses were performed using latently infected Jurkat T cells to evaluate the turnover of different epigenetic modifications at HIV LTR in the absence or presence of knockdown of endogenous CBF-1, using the indicated antibodies. Primer sets directed to the (<b>a</b>) Promoter region (−116 to +4) with respect to transcription start site; (<b>b</b>) Nucleosome 1 (+30 to +134) with respect to transcription start site of HIV-1 LTR. The depicted ChIP assay results were reproduced 5 times. Graphs represent the average and standard deviation from three independent and replicate samples. Statistical analysis was calculated with GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). The <span class="html-italic">p</span> value of statistical significance was set at either; <span class="html-italic">p</span> &lt; 0.05 (*) or 0.01 (**).</p>
Full article ">Figure 4
<p>CBF-1 knockdown resulted in dissociation of different factors belonging to both PRCs (PRC1 and PRC2). ChIP analyses were performed using latently infected Jurkat T cells in the absence or presence of CBF-1 knockdown. CBF-1 knockdown leads to the dissociation of various core components of both PRCs, showing the role of CBF-1 in their recruitment at HIV LTR. (<b>a</b>) Promoter region (−116 to +4); (<b>b</b>) Nucleosome 1 (+30 to +134). Error bars represent the SEM of three independent experiments and three separate qPCR measurements from each experiment. Graphs represent the average and standard deviation from three independent and replicate samples. Statistical analysis was calculated with GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). The <span class="html-italic">p</span> value of statistical significance was set at either; <span class="html-italic">p</span> &lt; 0.05 (*) or 0.01 (**).</p>
Full article ">Figure 5
<p>Cell activation leads to fluctuation in the levels of different chromatin-associated factors that belong to PRC1 and PRC2. ChIP analyses were performed before and after activation of latently infected primary CD4+ T cells with α-CD3/-CD28 antibodies, in the presence of IL-2 for 30 min. (<b>a</b>) Structure of lentiviral vectors. mCherry was used as reporter depicted in this diagram. ChIP results in latency systems harboring proviruses with the vector pHR’-PNL-H13LTat-mCherry (<b>b</b>,<b>c</b>), and pHR’-PNL-wild-typeTat-mCherry (<b>d</b>,<b>e</b>). Error bars represent the SEM of two independent experiments and three separate qPCR measurements from each analysis. Graphs represent the average and standard deviation from three independent and replicate samples. Statistical analysis was calculated with GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA). The <span class="html-italic">p</span> value of statistical significance was set at either; <span class="html-italic">p</span> &lt; 0.05 (*) or 0.01 (**).</p>
Full article ">Figure 6
<p>Model of CBF-1 functioning. Based on our findings, we propose the following model for the regulation of HIV latency by CBF-1. The higher levels of CBF-1 and lack of transcription factors such as NF-kB and NFAT in quiescent cells facilitates the binding of CBF-1 at HIV LTR. CBF-1 after binding to LTR recruits PRCs. PRCs subsequently promote heterochromatin environment at HIV LTR and inhibit the free flow of transcription machinery, thus facilitating the establishment and maintenance of HIV latency. Following cellular activation, the levels of CBF-1 drop, but the levels of NF-kB and NFAT rise in the nucleus, which displaces CBF-1 and corepressor complexes from their binding sites. Eventually, these factors recruit coactivator complexes at HIV LTR, which then establishes the euchromatin environment at HIV LTR that facilitate the access of transcription machinery at the LTR promoter, and thus leads to the reactivation of latent proviruses.</p>
Full article ">
19 pages, 1184 KiB  
Review
Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses
by Ping Liu, Yan Hong, Bincai Yang, Prasha Shrestha, Nelam Sajjad and Ji-Long Chen
Viruses 2020, 12(9), 1039; https://doi.org/10.3390/v12091039 - 18 Sep 2020
Cited by 10 | Viewed by 5245
Abstract
Some coronaviruses are zoonotic viruses of human and veterinary medical importance. The novel coronavirus, severe acute respiratory symptoms coronavirus 2 (SARS-CoV-2), associated with the current global pandemic, is characterized by pneumonia, lymphopenia, and a cytokine storm in humans that has caused catastrophic impacts [...] Read more.
Some coronaviruses are zoonotic viruses of human and veterinary medical importance. The novel coronavirus, severe acute respiratory symptoms coronavirus 2 (SARS-CoV-2), associated with the current global pandemic, is characterized by pneumonia, lymphopenia, and a cytokine storm in humans that has caused catastrophic impacts on public health worldwide. Coronaviruses are known for their ability to evade innate immune surveillance exerted by the host during the early phase of infection. It is important to comprehensively investigate the interaction between highly pathogenic coronaviruses and their hosts. In this review, we summarize the existing knowledge about coronaviruses with a focus on antiviral immune responses in the respiratory and intestinal tracts to infection with severe coronaviruses that have caused epidemic diseases in humans and domestic animals. We emphasize, in particular, the strategies used by these coronaviruses to circumvent host immune surveillance, mainly including the hijack of antigen-presenting cells, shielding RNA intermediates in replication organelles, 2′-O-methylation modification for the evasion of RNA sensors, and blocking of interferon signaling cascades. We also provide information about the potential development of coronavirus vaccines and antiviral drugs. Full article
Show Figures

Figure 1

Figure 1
<p>Architecture of the mucosal epithelial barrier in the respiratory and intestinal tracts that guards against viral invasion. (<b>A</b>). The airway epithelium is composed of ciliated cells, goblet cells, basal cells, and Clara cells. The mucus on the epithelial surface is the first barrier against human infection by coronaviruses, such as SARS-CoV, MERS-CoV, and the novel emerging coronavirus, SARS-CoV-2. The mucins secreted by goblet cells on the epithelial surface include two layers, a viscous layer on top and a periciliary layer below. The innate immune cells in the submucosal layer such as dendritic cells and macrophages are involved in controlling viral infection. (<b>B</b>) Enteric coronaviruses, such as PEDV and PDCoV, principally infect swine by causing histopathological lesions in the intestinal tract. In spite of their similar histological structures, there are substantial differences in the functional purposes and internal environments of the gut and respiratory tract. The mucus of the intestinal tract mainly consists of MUC2 mucin, antimicrobial peptides, and secreted IgA (sIgA) produced by goblet cells, Paneth cells, and plasma cells, respectively. In particular, the commensal bacterial communities resident in the mucus of the gut are involved in various physiological processes that modulate the homeostasis of mucosal immunity. In addition, the intraepithelial lymphocytes (IELs) are located between intestinal epithelial cells, and these cells constitute a large and highly conserved T cell compartment. Intestinal microfold cells (M cells) are only found in the gut-associated lymphoid tissues (GALT) of Peyer’s patches in the intestinal tract, and they are unique antigen-presenting cells that are important for the initiation of mucosal immune responses. The diverse immune cells reside in the <span class="html-italic">lamina propria</span> and mainly include B cells, T cells, dendritic cells, and macrophages. These immune cells interact with the epithelium to detect invading pathogens.</p>
Full article ">Figure 2
<p>Schematic diagram of the antiviral immune response and evasion mechanism of coronaviruses. Coronaviruses are internalized into susceptible target cells by the fusion of viral and cellular membranes with unique receptors, such as ACE2, DPP4, and APN, and the RNA of the viral genome is released into the cytosol. SARS-CoV and SARS-CoV-2 exploit the serine protease TMPRSS2 for spike protein priming. The virion and the pathogen-associated molecular patterns (PAMPs) of coronavirus can be recognized by immune sensors called pattern-recognition receptors (PRRs), such as toll-like receptors (TLRs) and cytoplasm retinoic acid-inducible gene (RIG) type I like receptors (RLRs) (RIG-I/MDA5). The extracellular membrane of TLRs (TLR2/4) and endosome TLRs (TLR3/7/8) are widely expressed in epithelial cells and dendritic cells. The PAMPs of coronaviruses induce the interferon (IFN) signaling pathway for antiviral innate immune responses. RIG-I/MDA5 conveys signals through mitochondrial antiviral-signaling protein (MAVS), while TLRs signal through TIR-containing adapter protein inducing IFN-β/myeloid differentiation factor 88 (TRIF/MyD88). TNF receptor-associated factor 3 (TRAF3) activates tank-binding kinase 1/IκB kinase epsilon (TBK1/IKKε), while TRAF6 signal transduction requires activation of the IKK complex. Activated transcription factors are translocated into the nucleus to promote Type I and III IFN expression. IFNs are secreted into the extracellular space and bound to their cognate receptors IFNAR and IFNLR (IFNLR1 and IL10Rβ) to activate downstream the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, followed by nuclear localization of the interferon-stimulated gene factor 3 (ISGF3) complex and expression of numerous interferon stimulating genes (ISGs), leading to the establishment of an antiviral state. Suppression of IFN signal pathways by coronaviruses and their antagonists is shown in red boxes. S, severe acute respiratory symptom coronavirus (SARS-CoV); M, Middle East respiratory syndrome coronavirus (MERS-CoV); P, porcine epidemic diarrhea virus (PEDV); PD, porcine Deltacoronavirus (PDCoV); ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; TMPRSS2, transmembrane serine protease 2.</p>
Full article ">
16 pages, 3618 KiB  
Article
The Genetic Diversification of a Single Bluetongue Virus Strain Using an In Vitro Model of Alternating-Host Transmission
by Jennifer H. Kopanke, Justin S. Lee, Mark D. Stenglein and Christie E. Mayo
Viruses 2020, 12(9), 1038; https://doi.org/10.3390/v12091038 - 18 Sep 2020
Cited by 9 | Viewed by 3421
Abstract
Bluetongue virus (BTV) is an arbovirus that has been associated with dramatic epizootics in both wild and domestic ruminants in recent decades. As a segmented, double-stranded RNA virus, BTV can evolve via several mechanisms due to its genomic structure. However, the effect of [...] Read more.
Bluetongue virus (BTV) is an arbovirus that has been associated with dramatic epizootics in both wild and domestic ruminants in recent decades. As a segmented, double-stranded RNA virus, BTV can evolve via several mechanisms due to its genomic structure. However, the effect of BTV’s alternating-host transmission cycle on the virus’s genetic diversification remains poorly understood. Whole genome sequencing approaches offer a platform for investigating the effect of host-alternation across all ten segments of BTV’s genome. To understand the role of alternating hosts in BTV’s genetic diversification, a field isolate was passaged under three different conditions: (i) serial passages in Culicoides sonorensis cells, (ii) serial passages in bovine pulmonary artery endothelial cells, or (iii) alternating passages between insect and bovine cells. Aliquots of virus were sequenced, and single nucleotide variants were identified. Measures of viral population genetics were used to quantify the genetic diversification that occurred. Two consensus variants in segments 5 and 10 occurred in virus from all three conditions. While variants arose across all passages, measures of genetic diversity remained largely similar across cell culture conditions. Despite passage in a relaxed in vitro system, we found that this BTV isolate exhibited genetic stability across passages and conditions. Our findings underscore the valuable role that whole genome sequencing may play in improving understanding of viral evolution and highlight the genetic stability of BTV. Full article
(This article belongs to the Section Invertebrate Viruses)
Show Figures

Figure 1

Figure 1
<p>Experimental Set-up. A field isolate of bluetongue virus (BTV)-17 (BTV17-INPUT) was passaged under three different cell culture conditions: serial passages in bovine cells (BTV17-BPAEC); serial passages in <span class="html-italic">Culicoides sonorensis</span> cells (BTV17-CUVA); and alternating passages in bovine and <span class="html-italic">C. sonorensis</span> cells (BTV17-ALT) for 10 consecutive passages.</p>
Full article ">Figure 2
<p>BTV Genetic Distance by Segment across Cell Culture Conditions. Genetic distances (the sum of single nucleotide variant (SNV) frequencies per segment) were normalized by each segments’ coding sequence length. Segments 1–10 are represented along the <span class="html-italic">x</span>-axis (s1, s2, s3, s4, s5, s6, s7, s8, s9, and s10). For BTV17-CUVA, -ALT, and -BPAEC, mean distance (and standard deviation) for each segment across passages 3, 6, and 9 is shown.</p>
Full article ">Figure 3
<p>BTV Genetic Richness across Cell Culture Conditions. (<b>a</b>) Richness of each segment was calculated as the sum of single nucleotide variants (SNV) sites normalized by the number of BTV reads (i.e., variant sites per 10,000 BTV reads), and collective data across all segments are shown by box-and-whisker plots (median, interquartile range, and minimum/maximum are depicted; *** = <span class="html-italic">p</span> &lt; 0.005). Box-and-whisker plots for BTV17-CUVA, -ALT, and -BPAEC were constructed using the richness of all segments across passages 3, 6, and 9. (<b>b</b>) Mean richness and standard deviation for each segment are shown. Segments 1–10 are represented along the <span class="html-italic">x</span>-axis (s1, s2, s3, s4, s5, s6, s7, s8, s9, and s10). Bars depicting BTV17-CUVA, -ALT, and -BPAEC represent collective data from passages 3, 6, and 9.</p>
Full article ">Figure 4
<p>BTV Genetic Complexity across Cell Culture Conditions. Shannon entropy was calculated as a measure of population complexity across viral coding sequences. Shannon entropy was calculated for each segment and cumulative data from all segments are shown by box-and-whisker plots (median, interquartile range, and minimum/maximum are depicted; *** = <span class="html-italic">p</span> &lt; 0.005). Box-and-whisker plots for BTV17-CUVA, -ALT, and -BPAEC were constructed using the mean Shannon entropy of all segments across passages 3, 6, and 9.</p>
Full article ">Figure 5
<p>BTV Genetic Complexity by Segment across Cell Culture Conditions. Shannon entropy was calculated for each segment as a measure of viral population complexity. Segments 1–10 are represented along the <span class="html-italic">x</span>-axis (s1, s2, s3, s4, s5, s6, s7, s8, s9, and s10). For BTV17-CUVA, -ALT, and -BPAEC, mean Shannon entropy (and standard deviation) for each segment across passages 3, 6, and 9 are shown.</p>
Full article ">Figure 6
<p>SNVs and Indels by Passage and Cell Culture Condition. The total number of novel SNVs or indels was calculated for each sample and normalized by the nucleotide length of the coding sequence (CDS) of each segment. The mean number of normalized novel sites per segment is plotted according to passage and cell culture condition. Segments 1–10 are represented in each bar graph (s1, s2, s3, s4, s5, s6, a7, s8, s9, s10). Viruses harvested from each condition at passage 3 (CuVa p3, Alternate (Alt) p3, and BPAEC p3), passage 6 (CuVa p6, Alt p6, BPAEC p6) and passage 9 (CuVa p9, Alt p9, BPAEC p9) are depicted.</p>
Full article ">Figure 7
<p>Genetic Selection by Segment and Cell Culture Condition. The proportion of nonsynonymous (dN) to synonymous (dS) changes was used as an estimate of selection. (<b>a</b>) dN/dS for each sample was calculated across the entire BTV coding sequence (CDS; inclusive of all ten segments), *** = <span class="html-italic">p</span> &lt; 0.0005. (<b>b</b>) dN/dS from all passages and replicates are shown. Error bars depict mean and standard deviation of each segment according to cell culture condition. BTV17-INPUT is shown by black dots and the dashed line. Segments 1–10 are represented along the <span class="html-italic">x</span>-axis (s1, s2, s3, s4, s5, s6, s7, s8, s9, and s10).</p>
Full article ">
15 pages, 1266 KiB  
Review
Functional Characterization of Pepper Vein Banding Virus-Encoded Proteins and Their Interactions: Implications in Potyvirus Infection
by Pallavi Sabharwal and Handanahal S. Savithri
Viruses 2020, 12(9), 1037; https://doi.org/10.3390/v12091037 - 17 Sep 2020
Cited by 4 | Viewed by 3707
Abstract
Pepper vein banding virus (PVBV) is a distinct species in the Potyvirus genus which infects economically important plants in several parts of India. Like other potyviruses, PVBV encodes multifunctional proteins, with several interaction partners, having implications at different stages of the potyviral infection. [...] Read more.
Pepper vein banding virus (PVBV) is a distinct species in the Potyvirus genus which infects economically important plants in several parts of India. Like other potyviruses, PVBV encodes multifunctional proteins, with several interaction partners, having implications at different stages of the potyviral infection. In this review, we summarize the functional characterization of different PVBV-encoded proteins with an emphasis on their interaction partners governing the multifunctionality of potyviral proteins. Intrinsically disordered domains/regions of these proteins play an important role in their interactions with other proteins. Deciphering the function of PVBV-encoded proteins and their interactions with cognitive partners will help in understanding the putative mechanisms by which the potyviral proteins are regulated at different stages of the viral life-cycle. This review also discusses PVBV virus-like particles (VLPs) and their potential applications in nanotechnology. Further, virus-like nanoparticle-cell interactions and intracellular fate of PVBV VLPs are also discussed. Full article
(This article belongs to the Special Issue The Complexity of the Potyviral Interaction Network)
Show Figures

Figure 1

Figure 1
<p>Genome organization of viruses belonging to <span class="html-italic">Potyvirus</span> genus, indicating the transcriptional slippage at the slippery sequences and polyprotein processing by the viral-encoded proteases to form mature proteins. Pink arrow at the P1 and orange arrow at the HC-Pro cleavage sites indicate self-cleavage of the two proteases. Red arrows indicate <span class="html-italic">trans</span> cleavage by VPg-Pro and black arrows indicate the <span class="html-italic">cis</span> cleavage by VPg-Pro.</p>
Full article ">Figure 2
<p>Effect of ionic strength and pH in the disassembly of pepper vein-banding virus (PVBV) virus-like particles (VLPs). At pH &lt; 6.5 and a low ionic strength, VLPs are the dominant species which get dissociated into 16 S ring and further into coat protein (CP) subunits (monomer/dimer) as the ionic strength keeps on increasing. As the pH increases, even a low ionic strength is sufficient to disassemble the VLPs into ring intermediate. At higher ionic strength (&gt;0.9 M) and high pH (&gt;10), VLPs are completely dissociated into individual CP subunits.</p>
Full article ">Figure 3
<p>Schematic representation of the generation of chimeric VLPs and their potential applications (<b>a</b>) IgG-binding B-domain is cloned at the N-terminus of CP gene which assembles to form PVBV chimeric VLPs with each subunit expressing the B-domain at its N-terminus (<b>b</b>) Incubating the PVBV chimeric VLPs with anti-α tubulin antibody led to the formation of chimeric VLPs + antibody complex (<b>c</b>) PVBV chimeric VLPs, protein A as well as the monomer BCP (PVBV CP N-terminal fusion with B-domain) subunit + antibody complex were subjected to DAC ELISA (direct antigen coating-enzyme linked immunosorbent assay) where an antibody unrelated to CP was used. The dissociation constant (Kd) for each of the complexes is depicted, indicating an approximately 500-fold higher antibody-binding affinity of chimeric VLPs when compared to protein A (<b>d</b>) chimeric VLPs + anti-α tubulin antibody complex could internalize into mammalian cells and deliver the functional tubulin antibodies, which caused the disruption of the tubulin network ultimately causing cell death (<b>e</b>) whereas the BCP monomer (Ni-NTA purified BCP after size exclusion chromatography) + antibody complex fail to enter the mammalian cells.</p>
Full article ">
15 pages, 1991 KiB  
Article
Molecular Characterisation of a Novel and Highly Divergent Passerine Adenovirus 1
by Ajani Athukorala, Jade K. Forwood, David N. Phalen and Subir Sarker
Viruses 2020, 12(9), 1036; https://doi.org/10.3390/v12091036 - 17 Sep 2020
Cited by 15 | Viewed by 4515
Abstract
Wild birds harbour a large number of adenoviruses that remain uncharacterised with respect to their genomic organisation, diversity, and evolution within complex ecosystems. Here, we present the first complete genome sequence of an atadenovirus from a passerine bird that is tentatively named Passerine [...] Read more.
Wild birds harbour a large number of adenoviruses that remain uncharacterised with respect to their genomic organisation, diversity, and evolution within complex ecosystems. Here, we present the first complete genome sequence of an atadenovirus from a passerine bird that is tentatively named Passerine adenovirus 1 (PaAdV-1). The PaAdV-1 genome is 39,664 bp in length, which was the longest atadenovirus to be sequenced, to the best of our knowledge, and contained 42 putative genes. Its genome organisation was characteristic of the members of genus Atadenovirus; however, the novel PaAdV-1 genome was highly divergent and showed the highest sequence similarity with psittacine adenovirus-3 (55.58%). Importantly, PaAdV-1 complete genome was deemed to contain 17 predicted novel genes that were not present in any other adenoviruses sequenced to date, with several of these predicted novel genes encoding proteins that harbour transmembrane helices. Subsequent analysis of the novel PaAdV-1 genome positioned phylogenetically to a distinct sub-clade with all others sequenced atadenoviruses and did not show any obvious close evolutionary relationship. This study concluded that the PaAdV-1 complete genome described here is not closely related to any other adenovirus isolated from avian or other natural host species and that it should be considered a separate species. Full article
(This article belongs to the Special Issue Animal and Wildlife Viruses)
Show Figures

Figure 1

Figure 1
<p>Schematic illustration of the avian atadenoviruses. Schematic map of the passerine adenovirus 1 (PaAdV-1, GenBank accession no. MT674683), in comparison with duck adenovirus A (DAdV-A, GenBank accession no. AC_000004) and psittacine adenovirus 3 (PsAdV-3, GenBank accession no. KJ675568), using CLC Genomic Workbench (version 9.5.4, CLC bio, a QIAGEN Company, Prismet, Aarhus C, Denmark). The arrows symbolize adenovirus genes and open reading frames (ORFs) predicted to code for proteins, indicating their direction of transcription. Each gene or ORF is colour coded, as indicated by the colour key in the legend. The bottom graph represents the sequence conservation between the aligned PaAdV-1, DAdV-A, and PsAdV-3 sequences at a given coordinate at each position in the alignment. The gradient of the colour reflects the conservation of that particular position is in the alignment. Red presents 100% conservation across all three viruses, black 50% conserved regions, and blue less than 50% conserved regions.</p>
Full article ">Figure 2
<p>Predicted structure of the unique PaAdV1-ORF10. (<b>A</b>) prediction of transmembrane helices (TMHs) in unique PaAdV1-ORF10 gene using EMBOSS 6.5.7 tool in Geneious (version 10.2.2) (<b>A</b>), TMHMM (<b>B</b>), and TMpred (<b>C</b>). All the programs consistently predicted two TMHs. (<b>A</b>) TMHs detected by EMBOSS also showed the presence of alpha-helices within TMHs predicted region that has been dominated by highly hydrophobic residue (red colour). (<b>B</b>,<b>C</b>) The <span class="html-italic">x</span>-axis represents the position of residue, whereas <span class="html-italic">y</span>-axis represents the posterior probability (<b>B</b>), and scores (above 500 are considered significant) (<b>C</b>) for the predicted TMHs. (<b>C</b>) Solid and dashed black lines indicate protein orientation as inside to outside, and outside to inside, respectively.</p>
Full article ">Figure 3
<p>Predicted structure of the unique PaAdV1-ORF18. (<b>A</b>) prediction of transmembrane helices (TMHs) in unique PaAdV1-ORF18 gene, using EMBOSS 6.5.7 tool in Geneious (version 10.2.2) (<b>A</b>), TMHMM (<b>B</b>), and TMpred (<b>C</b>). All the programs consistently predicted two TMHs. (A) TMHs detected by EMBOSS also showed the presence of alpha-helices within TMHs predicted region that has been dominated by highly hydrophobic residue (red colour). (<b>B</b>,<b>C</b>) The <span class="html-italic">x</span>-axis represents the position of residue, whereas the <span class="html-italic">y</span>-axis represents the posterior probability (<b>B</b>) and scores (above 500 were considered significant) (<b>C</b>) for the predicted TMHs. (<b>C</b>) Solid and dashed black lines indicate protein orientation as inside to outside, and outside to inside, respectively.</p>
Full article ">Figure 4
<p>Phylogenetic tree shows the possible evolutionary relationship of novel passerine adenovirus 1 with other selected AdVs. Maximum likelihood (ML) tree was constructed by using concatenated amino acid sequences of the complete DNA-dependent DNA polymerase, pTP, penton, and hexon genes. Concatenated protein sequences were aligned with MAFTT (version 7.450) [<a href="#B41-viruses-12-01036" class="html-bibr">41</a>] in Geneious (version 10.2.2, Biomatters, Ltd., Auckland, New Zealand), under the BLOSUM62 scoring matrix and gap open penalty = 1.53. The gap &gt;20 residues deleted from the alignments. The unrooted ML tree was constructed with PhyML [<a href="#B42-viruses-12-01036" class="html-bibr">42</a>] under the LG substitution model, and 1000 bootstrap re-samplings were chosen to generate ML trees, using tools available in Geneious (version 10.2.2, Biomatters, Ltd., Auckland, New Zealand). The numbers on the left show bootstrap values as percentages, and the labels at branch tips refer to original AdVs species name, followed by GenBank accession number in parentheses. The final tree is visualised with FigTree (version 1.4.4) [<a href="#B43-viruses-12-01036" class="html-bibr">43</a>]. The five official genera are highlighted as different background colours, and novel passerine adenovirus 1 is shown in pink colour.</p>
Full article ">
13 pages, 1561 KiB  
Article
Evolutionary Study of the Crassphage Virus at Gene Level
by Alessandro Rossi, Laura Treu, Stefano Toppo, Henrike Zschach, Stefano Campanaro and Bas E. Dutilh
Viruses 2020, 12(9), 1035; https://doi.org/10.3390/v12091035 - 17 Sep 2020
Cited by 9 | Viewed by 4538
Abstract
crAss-like viruses are a putative family of bacteriophages recently discovered. The eponym of the clade, crAssphage, is an enteric bacteriophage estimated to be present in at least half of the human population and it constitutes up to 90% of the sequences in some [...] Read more.
crAss-like viruses are a putative family of bacteriophages recently discovered. The eponym of the clade, crAssphage, is an enteric bacteriophage estimated to be present in at least half of the human population and it constitutes up to 90% of the sequences in some human fecal viral metagenomic datasets. We focused on the evolutionary dynamics of the genes encoded on the crAssphage genome. By investigating the conservation of the genes, a consistent variation in the evolutionary rates across the different functional groups was found. Gene duplications in crAss-like genomes were detected. By exploring the differences among the functional categories of the genes, we confirmed that the genes encoding capsid proteins were the most ubiquitous, despite their overall low sequence conservation. It was possible to identify a core of proteins whose evolutionary trees strongly correlate with each other, suggesting their genetic interaction. This group includes the capsid proteins, which are thus established as extremely suitable for rebuilding the phylogenetic tree of this viral clade. A negative correlation between the ubiquity and the conservation of viral protein sequences was shown. Together, this study provides an in-depth picture of the evolution of different genes in crAss-like viruses. Full article
Show Figures

Figure 1

Figure 1
<p>Number of sequences in each group of protein homologs (cluster size) according to functional categories. The three color bars refer to the different similarity thresholds applied to filter alignments (50%, 80%, and 95% respectively). The capsid proteins are the most frequently present in the crAss-like contigs. See <a href="#app1-viruses-12-01035" class="html-app">Table S2</a> for the names of all homologous groups of proteins and values for all statistics.</p>
Full article ">Figure 2
<p>Correlation between the logarithm of the number of sequences in a protein family and the Shannon information content of the positions in the protein sequence alignment. Inverse correlations were obtained both for crAss-like viruses and pVOGs. For proteins in crAss-like viruses, only functional classes having more than four genes are reported.</p>
Full article ">Figure 3
<p>Mirrortree algorithm applied to the homologous groups of proteins. Histogram representing the distribution of the pairwise Pearson’s r coefficients. A great number of genes appear to be coevolving. Heatmap of the Pearson correlation coefficient of each protein with any other. Along the x and y axis the 92 ORFs identified in the reference crAssphage genome are represented. The interactions between clusters sharing less than five sequences were colored in white, in order to avoid confusion due to a low size. Histogram representing the average correlation coefficient of every protein represented in their position on the reference genome. The different colors represent the six functional groups.</p>
Full article ">
20 pages, 3415 KiB  
Review
Regulation of KSHV Latency and Lytic Reactivation
by Grant Broussard and Blossom Damania
Viruses 2020, 12(9), 1034; https://doi.org/10.3390/v12091034 - 17 Sep 2020
Cited by 77 | Viewed by 8467
Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) is associated with three malignancies— Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). Central to the pathogenesis of these diseases is the KSHV viral life cycle, which is composed of a quiescent latent phase and [...] Read more.
Kaposi’s sarcoma-associated herpesvirus (KSHV) is associated with three malignancies— Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). Central to the pathogenesis of these diseases is the KSHV viral life cycle, which is composed of a quiescent latent phase and a replicative lytic phase. While the establishment of latency enables persistent KSHV infection and evasion of the host immune system, lytic replication is essential for the dissemination of the virus between hosts and within the host itself. The transition between these phases, known as lytic reactivation, is controlled by a complex set of environmental, host, and viral factors. The effects of these various factors converge on the regulation of two KSHV proteins whose functions facilitate each phase of the viral life cycle—latency-associated nuclear antigen (LANA) and the master switch of KSHV reactivation, replication and transcription activator (RTA). This review presents the current understanding of how the transition between the phases of the KSHV life cycle is regulated, how the various phases contribute to KSHV pathogenesis, and how the viral life cycle can be exploited as a therapeutic target. Full article
(This article belongs to the Special Issue New Advances in Kaposi's Sarcoma-Associated Herpesvirus Research)
Show Figures

Figure 1

Figure 1
<p>The Kaposi’s sarcoma-associated herpesvirus (KSHV) genome enters a latent state after de novo infection. In some cells, early expression of lytic genes such as replication and transcription activator (RTA) triggers expression of the master organizer of latency, latency-associated nuclear antigen (LANA). LANA recruits many components of the host epigenetic machinery to promote the formation of latent KSHV episomes. A pattern of transcriptionally-permissive histone modifications across the KSHV genome gives way to a generally-repressive chromatin state, sparing robust latent gene expression. Lytic gene expression becomes minimal but poised for upregulation upon reactivation.</p>
Full article ">Figure 2
<p>KSHV modulates host signaling pathways, chromatin structure, and gene expression to maintain latency. Viral proteins and miRNAs stimulate latency-promoting signaling pathways and chromatin modifiers. The expression and function of RTA is restricted by a variety of proteins and miRNAs from the virus and the host. LANA promotes repressive histone modifications and regulatory loops. Lytic gene expression is minimal but poised for reactivation upon shifts in the relative activities of RTA and LANA.</p>
Full article ">Figure 3
<p>Environmental stimuli alter regulation of RTA to promote KSHV reactivation. Host signaling pathways integrate information about the cellular microenvironment that affects the expression and activity of RTA. Lytic viral proteins promote KSHV reactivation in a feed-forward loop. Various isoforms and posttranslational modifications of LANA switch it from an organizer of latency to a facilitator of the lytic cycle. The cell-intrinsic immune system is antagonized by host and viral factors to augment viral reactivation.</p>
Full article ">Figure 4
<p>The latent and lytic stages of the KSHV life cycle drive pathogenesis. Latency maintains a population of infected cells by segregating KSHV episomes to daughter cells after mitosis. Lytic reactivation produces infectious virions that expand the pool of infected cells. Both latent and lytic factors promote tumor growth through viral oncogenes or paracrine factors. Lytic replication is sensitive to chemical inhibition, while latent episomes are difficult to target. Therapeutic interventions can force the virus out of latency, promoting cell death.</p>
Full article ">
19 pages, 5398 KiB  
Review
Progress in the Development of Universal Influenza Vaccines
by Wenqiang Sun, Tingrong Luo, Wenjun Liu and Jing Li
Viruses 2020, 12(9), 1033; https://doi.org/10.3390/v12091033 - 17 Sep 2020
Cited by 33 | Viewed by 5735
Abstract
Influenza viruses pose a significant threat to human health. They are responsible for a large number of deaths annually and have a serious impact on the global economy. There are numerous influenza virus subtypes, antigenic variations occur continuously, and epidemic trends are difficult [...] Read more.
Influenza viruses pose a significant threat to human health. They are responsible for a large number of deaths annually and have a serious impact on the global economy. There are numerous influenza virus subtypes, antigenic variations occur continuously, and epidemic trends are difficult to predict—all of which lead to poor outcomes of routine vaccination against targeted strain subtypes. Therefore, the development of universal influenza vaccines still constitutes the ideal strategy for controlling influenza. This article reviews the progress in development of universal vaccines directed against the conserved regions of hemagglutinin (HA), neuraminidase (NA), and other structural proteins of influenza viruses using new technologies and strategies with the goals of enhancing our understanding of universal influenza vaccines and providing a reference for research into the exploitation of natural immunity against influenza viruses. Full article
(This article belongs to the Special Issue Influenza Virus Vaccines)
Show Figures

Figure 1

Figure 1
<p>Mutation frequency of different antigenic regions and surface amino acids in the hemagglutinin (HA) protein of influenza viruses. H1 represents the 3D structure of A/Puerto Rico/8/34 (H1N1) HA protein (PDB ID: 1RU7) on which the location and distribution of different antigenic regions (Ca1, Ca2, Sa, Sb, Cb, and H1C) are indicated. H3 represents the 3D structure of A/X-31 H3 subtype HA protein (PBD ID: 2VIU) illustrating the location and distribution of different antigenic regions (A, B, C, D, and E). B represents the 3D structure of B/Lee/40 B subtype HA protein (PDB ID: 1RFT) highlighting the location and distribution of different antigenic regions (A, B, C, D, and E). H1 abs, H3 abs, and B abs illustrate the mutation frequency of surface amino acids on the respective HA proteins, with their color representing the intensity of mutation frequency based on H1N1 (<span class="html-italic">n</span> = 531, isolated between 1918–2008), H3N2 (<span class="html-italic">n</span> = 968, 1968–2005), and flu B (<span class="html-italic">n</span> = 209, 1940–2007).</p>
Full article ">Figure 2
<p>Phylogenetic tree of HAs of different subtypes (H1–H16) of influenza viruses. The phylogenetic tree was constructed using the neighbor-joining (NJ) method within MEGA software (version 7.0). The colors of the trees are edited using Adobe Illustrator software. The scale bar indicates the average number of amino acid substitutions per site.</p>
Full article ">Figure 3
<p>Schematic diagram of immune responses activated by different types of potential universal influenza vaccines. Universal influenza vaccines developed using different strategies involving different target proteins are administered by subcutaneous, intranasal, and intramuscular routes. The antigen is phagocytosed and processed by macrophages and other APC cells. Subsequently, B cell epitopes form a complex with MHC-II and are presented to the cell surface. Under the combined action of CD4 cells, B cells are activated to differentiate into plasma cells and secrete antibodies—e.g., anti-HA, anti-NA, anti-NP, anti-M2e, and anti-HA stem–to neutralize the virus. T cell epitopes—mainly, NP, M1, and HA stem—form a complex with MHC-I and are presented to the cell surface, under the action of CD8 cells and activate T cells to differentiate into CTLs to kill virus-infected cells.</p>
Full article ">
16 pages, 5904 KiB  
Article
Abrogating ALIX Interactions Results in Stuttering of the ESCRT Machinery
by Shilpa Gupta, Mourad Bendjennat and Saveez Saffarian
Viruses 2020, 12(9), 1032; https://doi.org/10.3390/v12091032 - 16 Sep 2020
Cited by 9 | Viewed by 3727
Abstract
Endosomal sorting complexes required for transport (ESCRT) proteins assemble on budding cellular membranes and catalyze their fission. Using live imaging of HIV virions budding from cells, we followed recruitment of ESCRT proteins ALIX, CHMP4B and VPS4. We report that the ESCRT proteins transiently [...] Read more.
Endosomal sorting complexes required for transport (ESCRT) proteins assemble on budding cellular membranes and catalyze their fission. Using live imaging of HIV virions budding from cells, we followed recruitment of ESCRT proteins ALIX, CHMP4B and VPS4. We report that the ESCRT proteins transiently co-localize with virions after completion of virion assembly for durations of 45 ± 30 s. We show that mutagenizing the YP domain of Gag which is the primary ALIX binding site or depleting ALIX from cells results in multiple recruitments of the full ESCRT machinery on the same virion (referred to as stuttering where the number of recruitments to the same virion >3). The stuttering recruitments are approximately 4 ± 3 min apart and have the same stoichiometry of ESCRTs and same residence time (45 ± 30 s) as the single recruitments in wild type interactions. Our observations suggest a role for ALIX during fission and question the linear model of ESCRT recruitment, suggesting instead a more complex co-assembly model. Full article
(This article belongs to the Special Issue The 11th International Retroviral Nucleocapsid and Assembly Symposium)
Show Figures

Figure 1

Figure 1
<p>Single versus multiple transient recruitments of ALIX into HIV Gag VLPs versus HIV Gag (YP<sup>−</sup>) VLPs. HeLa cells stably expressing ALIX–h30–eGFP were transfected with 1500 ng of Gag–mCherry (<b>A</b>,<b>B</b>) or Gag (YP<sup>−</sup>)–mCherry (<b>C</b>,<b>D</b>) and imaged 4 h after transfection. Assemblies of individual representative VLPs are shown with intensity plots (as gray dots and fitted with gray line) and cropped TIRF images of the Gag (top, gray) and ALIX (bottom, Blue) for (<b>A</b>) Gag-mChery VLPs and (<b>C</b>) Gag (YP<sup>−</sup>)–mCherry VLPs. Histograms of the first time (dark blue) and later recruitments (light blue) of ALIX are shown for (<b>B</b>) Gag-mChery VLPs and (<b>C</b>) Gag (YP<sup>−</sup>)–mCherry VLPs. The majority of the first ALIX recruitment took place within 1–10 min after the VLP assembly completing during both YP<sup>−</sup> and WT assembly.</p>
Full article ">Figure 2
<p>Single versus multiple transient recruitments of CHMP4 into HIV Gag VLPs versus HIV Gag (YP-) VLPs. HeLa cells were transfected with 900 ng of ΔCMV–eGFP–flex–CHMP4b and 600 ng (total 1500 ng plasmids) of Gag–mCherry (<b>A</b>,<b>B</b>) or Gag (YP-)–mCherry (<b>C</b>,<b>D</b>) and imaged 7 h after transfection. Assemblies of individual representative VLPs are shown with intensity plots (as gray dots and fitted with gray line) and cropped TIRF images of the Gag (top, gray) and CHMP4b (bottom, green) for (<b>A</b>) Gag–mCherry VLPs and (<b>C</b>) Gag (YP-)–mCherry VLPs. Histograms of the first time (dark green) and later recruitments (light Green) of CHMP4b are shown for (<b>B</b>) Gag–mCherry VLPs and (<b>C</b>) Gag (YP-)–mCherry VLPs. The majority of the first CHMP4b recruitment was within 1–10 min after the VLP assembly completed during both YP- and WT assembly.</p>
Full article ">Figure 3
<p>Single versus multiple transient recruitments of VPS4 into HIV Gag VLPs versus HIV Gag (YP-) VLPs.HeLa cells were transfected with 1200 ng of ΔCMV-VPS4-h37-mcherry and 300 ng (total 1500 ng of plasmids) of Gag–mCherry (<b>A</b>,<b>B</b>) or Gag (YP-)–mCherry (<b>C</b>,<b>D</b>) and imaged 7 h after transfection. Assemblies of individual representative VLPs are shown with intensity plots (as gray dots and fitted with gray line) and cropped TIRF images of the Gag (top, gray) and VPS4 (bottom, red) for (<b>A</b>) Gag–mCherry VLPs and (<b>C</b>) Gag (YP-)–mCherry VLPs. Histograms of the first time (dark red) and later recruitments (light red) of VPS4 are shown for (<b>B</b>) Gag-mChery VLPs and (<b>C</b>) Gag (YP-)–mCherry VLPs. The majority of the first VPS4 recruitment was within 1–10 min after the VLP assembly completed during both YP- and WT assembly.</p>
Full article ">Figure 4
<p>Multiple transient recruitments of VPS4 into HIV Gag WT and Gag (YP-) VLPs under ALIX depletion. HeLa cells were treated with two rounds of siRNA against ALIX. (<b>A</b>–<b>C</b>) HeLa ALIX–h37–eGFP cell line treated with siRNA against ALIX and then transfected with 1500 ng of Gag–mCherry WT. An individual multinucleated cell was chosen (<b>A</b>) and a representative HIV Gag–mCherry VLP assembly in this cell is shown in (<b>B</b>) with intensity plots (as gray dots and fitted with gray line) and cropped TIRF images of the Gag (top, gray) and ALIX (bottom, Blue). In 40 VLPs analyzed, there was no recruitment of ALIX, as shown in (<b>C</b>). HeLa cells were treated with siRNA against ALIX and then transfected with 1200 ng of ΔCMV–VPS4–h37–mCherry and 300 ng of HIV Gag–eGFP (<b>D</b>–<b>F</b>) and Gag (YP-)–eGFP (<b>G</b>–<b>I</b>). (<b>D</b>,<b>G</b>) Multinucleated cells chosen for experiments with (E&amp;H) showing a representative HIV Gag–mCherry (<b>E</b>) or HIV Gag (YP-)–mCherry (<b>H</b>) VLP assembly with intensity plots and cropped TIRF images of the Gag (top, gray) and VPS4 (bottom, Red). (<b>F</b>,<b>I</b>) Histograms of the number and timing of the first (dark red) and later recruitment (light red) of VPS4 in (<b>F</b>) HIV Gag–mCherry VLPs and (<b>I</b>) HIV Gag (YP<sup>−</sup>)–mCherry VLPs.</p>
Full article ">Figure 5
<p>Delayed transient recruitment of ALIX into HIV Gag (YP<sup>−</sup> + PTAP<sup>−</sup>) VLPs or HIV Gag (PTAP<sup>−</sup>) VLPs. HeLa cells stably expressing ALIX–h30–eGFP were transfected with 1500 ng of Gag (PTAP<sup>−</sup>)–mCherry (<b>A</b>,<b>B</b>) or Gag (PTAP<sup>−</sup> + YP<sup>−</sup>)–mCherry (<b>C</b>,<b>D</b>) and imaged 5 h after transfection. Intensity plots (as gray dots and fitted with gray line) of individual fully assembled representative VLPs are shown and cropped TIRF images of the Gag (top, gray) and AIX (bottom, blue) for (<b>A</b>) Gag(PTAP<sup>−</sup>)–mCherry VLPs and (<b>C</b>) Gag (PTAP<sup>−</sup> + YP<sup>−</sup>)–mCherry VLPs. Histograms of the first time (dark blue) and later recruitments (light blue) of ALIX are shown for (<b>B</b>) Gag (PTAP<sup>−</sup>)–mCherry VLPs and (<b>C</b>) Gag (PTAP<sup>−</sup> + YP<sup>−</sup>)–mCherry VLPs. Alix was recruited within 2 h after the start of the actual experiment.</p>
Full article ">
13 pages, 1874 KiB  
Communication
Avian Influenza Virus Prevalence and Subtype Diversity in Wild Birds in Shanghai, China, 2016–2018
by Ling Tang, Wangjun Tang, Xiaofang Li, Chuanxia Hu, Di Wu, Tianhou Wang and Guimei He
Viruses 2020, 12(9), 1031; https://doi.org/10.3390/v12091031 - 16 Sep 2020
Cited by 11 | Viewed by 3970
Abstract
From 2016 to 2018, surveillance of influenza A viruses in wild birds was conducted in Shanghai, located at the East Asian–Australian flyway, China. A total of 5112 samples from 51 species of wild birds were collected from three different wetlands. The total three-year [...] Read more.
From 2016 to 2018, surveillance of influenza A viruses in wild birds was conducted in Shanghai, located at the East Asian–Australian flyway, China. A total of 5112 samples from 51 species of wild birds were collected from three different wetlands. The total three-year prevalence of influenza A viruses among them was 8.8%, as assessed using real-time polymerase chain reaction (PCR) methods, and the total prevalence was higher in Anseriformes (26.3%) than in the Charadriiformes (2.3%) and the other orders (2.4%) in the Chongmin wetlands. Anseriformes should be the key monitoring group in future surveillance efforts. The peak prevalence of influenza A viruses in Charadriiformes were in April and September, and in other bird orders, the peaks were in November and December. Twelve subtypes of haemagglutinin (HA; H1–H12) and eight subtypes of neuraminidase (NA; N1, N2, N4–N9) were identified in 21 different combinations. The greatest subtype diversity could be found in common teal, suggesting that this species of the bird might play an important role in the ecology and epidemiology of influenza A viruses in Shanghai. These results will increase our understanding of the ecology and epidemiology of influenza A viruses in wild bird hosts in eastern China, and provide references for subsequent surveillance of influenza A virus in wild birds in this area. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Figure 1
<p>Locations of sampling sites at which the wild birds were monitored in Shanghai, 2016–2018. Shanghai is located in the East Asian–Australasian migratory wild bird flyway, which is marked with a yellow background. The locations of sampling sites are displayed using stars.</p>
Full article ">Figure 2
<p>Temporal variation of the overall number sampled and the avian influenza A virus (AIV) prevalence among wild birds during 2016–2018 in Shanghai. Data from 2016–2018 were pooled, the AIV positive rates were detected using quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR).</p>
Full article ">Figure 3
<p>Distribution of haemagglutinin (HA) subtypes, neuraminidase (NA) subtypes and HA/NA subtype combinations during influenza A virus surveillance in wild birds in Shanghai, 2016–2018. (<b>A</b>) Number of HA subtypes; (<b>B</b>) number of NA subtypes; (<b>C</b>). Number of HA/NA subtype combinations. HA/NA subtype combinations (blue) were colored according to the frequencies of detection.</p>
Full article ">Figure 4
<p>Correspondence plot showing the association between bird orders and HA, NA subtypes in two dimensions (singular value (SV)1 and SV2). All subtypes were detected during influenza A virus surveillance in wild birds in Shanghai, 2016-2018.</p>
Full article ">
16 pages, 3573 KiB  
Article
Detection and Phylogenetic Analyses of Taura Syndrome Virus from Archived Davidson’s-Fixed Paraffin-Embedded Shrimp Tissue
by Lauren Marie Ochoa, Roberto Cruz-Flores and Arun K. Dhar
Viruses 2020, 12(9), 1030; https://doi.org/10.3390/v12091030 - 16 Sep 2020
Cited by 11 | Viewed by 3889
Abstract
Taura syndrome is a World Organization for Animal Health (OIE)-listed disease of marine shrimp that is caused by Taura syndrome virus (TSV), a single-stranded RNA virus. Here we demonstrate the utility of using 15-year-old archived Davidson’s-fixed paraffin-embedded (DFPE) shrimp tissues for TSV detection [...] Read more.
Taura syndrome is a World Organization for Animal Health (OIE)-listed disease of marine shrimp that is caused by Taura syndrome virus (TSV), a single-stranded RNA virus. Here we demonstrate the utility of using 15-year-old archived Davidson’s-fixed paraffin-embedded (DFPE) shrimp tissues for TSV detection and phylogenetic analyses. Total RNA was isolated from known TSV-infected DFPE tissues using three commercially available kits and the purity and ability to detect TSV in the isolated RNA were compared. TSV was successfully detected through RT-qPCR in all the tested samples. Among the TSV-specific primers screened through RT-PCR, primer pair TSV-20 for the RNA-dependent RNA polymerase (RdRp), primers TSV-15 and TSV-16 for the capsid protein gene VP2 and primers TSV-5 for the capsid protein gene VP1 amplified the highest number of samples. To assess the phylogenetic relation among different TSV isolates, the VP1 gene was amplified and sequenced in overlapping segments. Concatenated sequences from smaller fragments were taken for phylogenetic analyses. The results showed that the TSV isolates from this study generally clustered with homologous isolates from the corresponding geographical regions indicating RNA derived from DFPE tissues can be used for pathogen detection and retrospective analyses. The ability to perform genomic characterization from archived tissue will expedite pathogen discovery, development of diagnostic tools and prevent disease spread in shrimp and potentially other aquaculture species worldwide. Full article
(This article belongs to the Section Animal Viruses)
Show Figures

Figure 1

Figure 1
<p>Taura syndrome virus (TSV) infection in <span class="html-italic">Litopenaeus vannamei</span>. (<b>A</b>) Focal acute-phase infection (large arrow) in the cuticular epithelium characterized by spherical intracytoplasmic inclusions bodies, pyknosis and karyorrhexis. Scale bar, 50 μM. (<b>B</b>) High magnification of the same section; the basophilic intracytoplasmic inclusions bodies (black arrow) and pyknotic nuclei (red arrow) are shown. Scale bar, 20 μM.</p>
Full article ">Figure 2
<p>Quantity and quality assessment of total RNA isolated from archived TSV-infected Davidson’s-fixed paraffin-embedded (DFPE) shrimp tissues. Each test was run in triplicate and a mean value for each data set was obtained. The figure in (<b>A</b>) shows a comparison of the mean nucleic acid concentrations for 29 samples from each extraction kit. The figure in (<b>B</b>) shows a comparison of the mean 260/230 ratio values for 29 samples from each extraction kit. The figure in (<b>C</b>) shows a comparison of the mean 260/280 ratio values for the 29 samples from each extraction kit. The horizontal line in each group represents a geometric mean of the data in the corresponding vertical data set.</p>
Full article ">Figure 2 Cont.
<p>Quantity and quality assessment of total RNA isolated from archived TSV-infected Davidson’s-fixed paraffin-embedded (DFPE) shrimp tissues. Each test was run in triplicate and a mean value for each data set was obtained. The figure in (<b>A</b>) shows a comparison of the mean nucleic acid concentrations for 29 samples from each extraction kit. The figure in (<b>B</b>) shows a comparison of the mean 260/230 ratio values for 29 samples from each extraction kit. The figure in (<b>C</b>) shows a comparison of the mean 260/280 ratio values for the 29 samples from each extraction kit. The horizontal line in each group represents a geometric mean of the data in the corresponding vertical data set.</p>
Full article ">Figure 3
<p>Analysis of the Ct values of TSV amplicons generated by RT-qPCR. Three commercially available extraction kits were utilized for total RNA extraction and total RNA isolated from archived TSV-infected DFPE shrimp tissues was used to generate a 72 bp amplicon of the TSV genome. The horizontal line in each group represents a geometric mean of the Ct values of the corresponding vertical data set. Asterisks represent statistical significance (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Representative agarose gel electrophoresis images for the detection of TSV genes and the internal control gene <span class="html-italic">EF-1α</span> (elongation factor 1-α). (<b>A</b>) TSV VP1 gene (primer pairs TSV-5, amplicon size 122 bp). (<b>B</b>) Shrimp <span class="html-italic">EF-1α</span> gene. SPF = Specific Pathogen Free negative control, NC = no template control, PC = TSV positive control. The first lane in each gel represents a molecular weight marker (Invitrogen 1 kb Plus DNA Ladder).</p>
Full article ">Figure 5
<p>A pictograph of the RT-PCR amplification of TSV capsid protein VP1 and VP2 genes, RNA-dependent RNA polymerase (RdRp) and shrimp internal control gene <span class="html-italic">EF-1α</span>. The primer pairs (TSV-1 to TSV-21) used to amplify different TSV genes are shown on the top row of the map. The case numbers are indicated in the far-left column (excluding Sample No. 25, as mentioned previously) and the total number of primer pairs (out of 21) that were successful in amplifying each sample can be seen in the far-right column. Green boxes indicate amplification and red boxes indicate no amplification for the corresponding primers.</p>
Full article ">Figure 6
<p>Phylogenetic analysis of TSV isolates. The evolutionary history was inferred using the neighbor-joining method. The optimal tree with the sum of branch length = 0.87629497 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches. The tree is drawn to scale with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of the number of base substitutions per site. This analysis included 12 samples from the present study (denoted by ** on the tree) and 29 GenBank accessions.</p>
Full article ">
21 pages, 2563 KiB  
Article
Identification and Distribution of Novel Cressdnaviruses and Circular Molecules in Four Penguin Species in South Georgia and the Antarctic Peninsula
by Hila Levy, Rafaela S. Fontenele, Ciara Harding, Crystal Suazo, Simona Kraberger, Kara Schmidlin, Anni Djurhuus, Caitlin E. Black, Tom Hart, Adrian L. Smith and Arvind Varsani
Viruses 2020, 12(9), 1029; https://doi.org/10.3390/v12091029 - 16 Sep 2020
Cited by 11 | Viewed by 4531
Abstract
There is growing interest in uncovering the viral diversity present in wild animal species. The remote Antarctic region is home to a wealth of uncovered microbial diversity, some of which is associated with its megafauna, including penguin species, the dominant avian biota. Penguins [...] Read more.
There is growing interest in uncovering the viral diversity present in wild animal species. The remote Antarctic region is home to a wealth of uncovered microbial diversity, some of which is associated with its megafauna, including penguin species, the dominant avian biota. Penguins interface with a number of other biota in their roles as marine mesopredators and several species overlap in their ranges and habitats. To characterize the circular single-stranded viruses related to those in the phylum Cressdnaviricota from these environmental sentinel species, cloacal swabs (n = 95) were obtained from King Penguins in South Georgia, and congeneric Adélie Penguins, Chinstrap Penguins, and Gentoo Penguins across the South Shetland Islands and Antarctic Peninsula. Using a combination of high-throughput sequencing, abutting primers-based PCR recovery of circular genomic elements, cloning, and Sanger sequencing, we detected 97 novel sequences comprising 40 ssDNA viral genomes and 57 viral-like circular molecules from 45 individual penguins. We present their detection patterns, with Chinstrap Penguins harboring the highest number of new sequences. The novel Antarctic viruses identified appear to be host-specific, while one circular molecule was shared between sympatric Chinstrap and Gentoo Penguins. We also report viral genotype sharing between three adult-chick pairs, one in each Pygoscelid species. Sequence similarity network approaches coupled with Maximum likelihood phylogenies of the clusters indicate the 40 novel viral genomes do not fall within any known viral families and likely fall within the recently established phylum Cressdnaviricota based on their replication-associated protein sequences. Similarly, 83 capsid protein sequences encoded by the viruses or viral-like circular molecules identified in this study do not cluster with any of those encoded by classified viral groups. Further research is warranted to expand knowledge of the Antarctic virome and would help elucidate the importance of viral-like molecules in vertebrate host evolution. Full article
(This article belongs to the Special Issue Viromics)
Show Figures

Figure 1

Figure 1
<p>Sampling sites of the four-penguin species based on their breeding colonies in South Georgia and the Antarctic Peninsula. The numbers in the pie chart indicate the number of individual samples per species.</p>
Full article ">Figure 2
<p>Heat map illustrating the dataset-wide detection scaled to sample size, of virus and circular molecule genotypes with the linearized genome organization shown on the right. The detection is based on the recovery of complete sequences by PCR, cloning, and Sanger sequencing. For the purpose of this study, the viruses and circular molecules have been classified as unique species based on a cutoff threshold of 80% genome-wide pairwise identity and genotypes based on 98% genome-wide pairwise identity. The penguin colony key is as follows: (first two letters) AP = Adélie Penguin, CP = Chinstrap Penguin, GP = Gentoo Penguin, and KP = King Penguin, followed by locations BOOT = Booth Island (Western Antarctic Peninsula), KINN = Kinnes Cove (Northern Antarctic Peninsula), BAIL = Baily Head (Deception Island), GEOR = Georges Point (Western Antarctic Peninsula), HALF = Half Moon Island (South Shetland Islands), MOOT = Moot Point (Western Antarctic Peninsula), YANK = Yankee Harbor (South Shetland Islands), and STA = St Andrews Bay (South Georgi).</p>
Full article ">Figure 3
<p>Sequence similarity network (SSN) analysis and Maximum likelihood (ML) phylogenetic tree of the Rep amino acid sequences identified in this study compared with those of known viruses in classified families and plasmids identified by Kazlauskas et al. [<a href="#B35-viruses-12-01029" class="html-bibr">35</a>]. The ML phylogenetic tree based on the SSN is mid-point rooted, and branches with aLRT support &lt; 0.8 have been collapsed. The Reps identified in this study are highlighted in green and relevant clades of the tree are shown in the expanded view. Sequences with taxa names CruV-203, -227, -319, and -320 are from metagenomic derived sequences reported in de la Higuera et al. [<a href="#B64-viruses-12-01029" class="html-bibr">64</a>] and do not have accession #s assigned. The level of branch support (&gt;0.8) is depicted as different sized shaded circles.</p>
Full article ">Figure 4
<p>Sequence similarity network (SSN) analysis and Maximum likelihood (ML) phylogenetic tree of the CP amino acid sequences that fall within specific networks that encompass sequences identified in this study (highlighted in purple). The ML phylogenetic trees based on the SSNs are mid-point rooted, and branches with aLRT support &lt; 0.8 have been collapsed. The level of branch support (&gt;0.8) is depicted as different sized shaded circles.</p>
Full article ">Figure 5
<p>Summary of the recombination detected by RDP4. The methods used to detect recombination are RDP (R) GENCONV (G), BOOTSCAN (B), MAXCHI (M), CHIMERA (C), SISCAN (S), and 3SEQ (T). The method with the highest p-value for each recombination event is bolded. For each genome, a graphic on the left indicates the recombination event with its breakpoint location within the genome. Roman numerals in parenthesis after accession numbers indicate genotype.</p>
Full article ">
Previous Issue
Next Issue
Back to TopTop